| Utestående aktier | 96,448,792 shares |
| Insideraktier | 24 330 551 shares |
| Insynsägande | 25,23 % |
| Totalt antal insynspersoner | 41 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
9957 out of 10786
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
CRISPR Therapeutics AG insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Aktiengesellschaft Bayer
10% Owner -
|
5 632 802 | 5 632 802 | |
|
Bayer Global Investments B.V.
10% Owner -
|
5 632 802 | 5 632 802 | |
| Ali Behbahani Director - [D] | 14 | 14 | |
| Bradley J PhD Bolzon Director - [D] | 148 831 | 148 831 | |
| Julianne Bruno Chief Operating Officer - [O] | 17 632 | 17 632 | |
| Pablo J Cagnoni Director - [D] | 0 | 0 | |
|
Corp /de/ Celgene
10% Owner -
|
3 722 534 | 3 722 534 | |
| N Anthony Coles Director - [D] | 70 000 | 70 000 | |
| Tyler Dylan-Hyde Chief Legal Officer - [O] | 25 204 | 25 204 | |
| Kurt Von Emster Director - [D] | 1 171 268 | 1 171 268 | |
|
Plc Glaxosmithkline
10% Owner -
|
3 220 627 | 3 220 627 | |
| Simeon George Director - [D] | 1 730 179 | 1 730 179 | |
| John Greene Director - [D] | 7 000 | 7 000 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Hadley Harbor Master Investors (Cayman) L.P.
10% Owner -
|
744 380 | 744 380 | |
| Katherine A High | 15 000 | ||
| Tony W Ho Executive VP, Head of R&D - [O] | 52 364 | 52 364 | |
| Kasinger James R. General Counsel and Secretary - [O] | 94 308 | 94 308 | |
| Lawrence Otto Klein CBO & COO - [O] | 26 797 | 26 797 | |
| Samarth Kulkarni Chief Executive Officer, Director - [D] [O] | 255 501 | 255 501 | |
| Sven Ante Lundberg Chief Scientific Officer - [O] | 505 617 | 505 617 | |
| Briggs Morrison Director - [D] | 10 418 | 10 418 | |
| Phuong Khanh Morrow Chief Medical Officer - [O] | 4 411 | 4 411 | |
| Rodger Novak President, Director - [D] [O] | 573 007 | 573 007 | |
| Naimish Patel Chief Medical Officer - [O] | 19 357 | 19 357 | |
| Raju Prasad Chief Financial Officer - [O] | 15 565 | 15 565 | |
| Brendan Smith Chief Financial Officer - [O] | 5 072 | 5 072 | |
| Kala Subramanian | 85 000 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Michael John Tomsicek Chief Financial Officer - [O] | 1 891 | 1 891 | |
| Douglas A Treco Director - [D] | 22 000 | 22 000 | |
|
Vertex Pharmaceuticals Inc / Ma
10% Owner -
|
5 380 940 | 5 380 940 | |
|
Versant Affiliates Fund V, L.P.
10% Owner -
|
115 645 | 115 645 | |
|
Versant Ophthalmic Affiliates I, L.P.
10% Owner -
|
115 645 | 115 645 | |
|
Versant Side Fund IV, L.P.
10% Owner -
|
117 173 | 117 173 | |
|
Versant Venture Capital IV, L.P.
10% Owner -
|
117 173 | 117 173 | |
|
Versant Venture Capital V (Canada), LP
10% Owner -
|
115 645 | 115 645 | |
|
Versant Venture Capital V, L.P.
10% Owner -
|
115 645 | 115 645 | |
|
Versant Ventures IV, LLC
10% Owner -
|
117 173 | 117 173 | |
|
Versant Ventures V (Canada), L.P.
10% Owner -
|
0 | 0 | |
|
Versant Ventures V, LLC
10% Owner -
|
115 645 | 115 645 | |
|
Pharmaceuticals (Europe) Ltd Vertex
10% Owner -
|
5 380 940 | 5 380 940 | |
| Thomas Woiwode Director - [D] | 640 014 | 640 014 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CRSP / CRISPR Therapeutics AG. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i CRSP / CRISPR Therapeutics AG. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | 2026-05-29 | 4 | Patel Naimish | CRSP | Common Shares | D | 55,6200 | −3 786 | −211 | 19 357 | ||||
| 2026-06-01 | 2026-05-28 | 4 | Patel Naimish | CRSP | Common Shares | D | 10 000 | 23 143 | ||||||
| 2026-03-24 | 2026-03-23 | 4 | Prasad Raju | CRSP | Common Shares | D | 46,7800 | −3 708 | −173 | 15 565 | ||||
| 2026-03-24 | 2026-03-20 | 4 | Prasad Raju | CRSP | Common Shares | D | 6 250 | 19 273 | ||||||
| 2026-03-24 | 2026-03-23 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 46,7800 | −10 020 | −469 | 255 501 | ||||
| 2026-03-24 | 2026-03-20 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19 687 | 265 521 | ||||||
| 2026-03-24 | 2026-03-23 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 46,7800 | −3 182 | −149 | 94 308 | ||||
| 2026-03-24 | 2026-03-20 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 6 250 | 97 490 | ||||||
| 2026-03-17 | 2026-03-16 | 4 | Patel Naimish | CRSP | Common Shares | D | 48,2600 | −3 150 | −152 | 13 143 | ||||
| 2026-03-17 | 2026-03-14 | 4 | Patel Naimish | CRSP | Common Shares | D | 8 125 | 16 293 | ||||||
| 2026-03-17 | 2026-03-16 | 4 | Prasad Raju | CRSP | Common Shares | D | −750 | 13 023 | ||||||
| 2026-03-17 | 2026-03-16 | 4 | Prasad Raju | CRSP | Common Shares | D | 48,2600 | −4 021 | −194 | 13 773 | ||||
| 2026-03-17 | 2026-03-16 | 4 | Prasad Raju | CRSP | Common Shares | D | 48,2600 | −5 848 | −282 | 17 794 | ||||
| 2026-03-17 | 2026-03-14 | 4 | Prasad Raju | CRSP | Common Shares | D | 6 875 | 23 642 | ||||||
| 2026-03-17 | 2026-03-14 | 4 | Prasad Raju | CRSP | Common Shares | D | 10 000 | 16 767 | ||||||
| 2026-03-17 | 2026-03-16 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 48,2600 | −3 450 | −166 | 91 240 | ||||
| 2026-03-17 | 2026-03-14 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 6 875 | 94 690 | ||||||
| 2026-03-17 | 2026-03-16 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 48,2600 | −10 349 | −499 | 245 834 | ||||
| 2026-03-17 | 2026-03-14 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 20 625 | 256 183 | ||||||
| 2026-03-12 | 2026-03-11 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 52,8000 | −9 798 | −517 | 235 558 | ||||
| 2026-03-12 | 2026-03-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19 250 | 245 356 | ||||||
| 2026-03-12 | 2026-03-11 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 52,8000 | −2 800 | −148 | 87 815 | ||||
| 2026-03-12 | 2026-03-10 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 5 500 | 90 615 | ||||||
| 2026-02-20 | 2026-02-19 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 52,5800 | −6 967 | −366 | 226 106 | ||||
| 2026-02-20 | 2026-02-18 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 13 250 | 233 073 | ||||||
| 2026-02-20 | 2026-02-19 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 52,5800 | −2 112 | −111 | 85 115 | ||||
| 2026-02-20 | 2026-02-18 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 3 825 | 87 227 | ||||||
| 2026-01-27 | 2025-04-03 | 4 | Patel Naimish | CRSP | Common Shares | D | 32,9600 | 1 508 | 50 | 1 508 | ||||
| 2026-01-26 | 2026-01-22 | 4 | Prasad Raju | CRSP | Common Shares | D | 60,1900 | −34 972 | −2 105 | 6 767 | ||||
| 2026-01-26 | 2026-01-22 | 4 | Prasad Raju | CRSP | Common Shares | D | 45,1500 | 34 972 | 1 579 | 41 739 | ||||
| 2026-01-22 | 2026-01-22 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 60,2300 | −60 000 | −3 614 | 134 201 | ||||
| 2026-01-22 | 2026-01-20 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 52,1000 | −8 567 | −446 | 194 201 | ||||
| 2026-01-22 | 2026-01-20 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 51,6100 | −21 433 | −1 106 | 202 768 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Prasad Raju | CRSP | Common Shares | D | 60,2134 | −5 763 | −347 | 6 767 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Prasad Raju | CRSP | Common Shares | D | 60,0000 | −5 004 | −300 | 12 530 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Prasad Raju | CRSP | Common Shares | D | 60,1799 | −18 933 | −1 139 | 17 534 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Prasad Raju | CRSP | Common Shares | D | 44,3100 | 6 339 | 281 | 36 467 | ||||
| 2026-01-08 | 2026-01-06 | 4 | Prasad Raju | CRSP | Common Shares | D | 45,1500 | 23 361 | 1 055 | 30 128 | ||||
| 2025-12-23 | 2025-12-22 | 4 | Prasad Raju | CRSP | Common Shares | D | 56,8858 | −1 000 | −57 | 6 767 | ||||
| 2025-12-23 | 2025-12-22 | 4 | Prasad Raju | CRSP | Common Shares | D | 56,3345 | −5 472 | −308 | 7 767 | ||||
| 2025-12-23 | 2025-12-22 | 4 | Prasad Raju | CRSP | Common Shares | D | 55,1022 | −3 528 | −194 | 13 239 | ||||
| 2025-12-22 | 2025-12-18 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | −30 000 | 224 201 | ||||||
| 2025-10-20 | 2025-10-17 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 67,9100 | −50 895 | −3 456 | 254 201 | ||||
| 2025-10-20 | 2025-10-16 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 100 000 | 305 096 | ||||||
| 2025-10-15 | 2025-10-14 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 66,6000 | −1 076 | −72 | 83 402 | ||||
| 2025-10-15 | 2025-10-13 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 2 114 | 84 478 | ||||||
| 2025-10-15 | 2025-10-14 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 66,6000 | −4 242 | −283 | 205 096 | ||||
| 2025-10-15 | 2025-10-13 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 8 334 | 209 338 | ||||||
| 2025-09-19 | 2025-09-17 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | −6 000 | 201 004 | ||||||
| 2025-08-19 | 2025-08-18 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 58,1500 | −13 081 | −761 | 207 004 | ||||
| 2025-08-19 | 2025-08-16 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 25 000 | 220 085 | ||||||
| 2025-08-08 | 2025-08-06 | 4 | Treco Douglas A | CRSP | Common Shares | D | 57,0300 | 20 000 | 1 141 | 22 000 | ||||
| 2025-07-17 | 2025-07-16 | 4 | George Simeon See Note 3 | CRSP | Common Shares | I | 52,0300 | 960 983 | 50 000 | 1 730 179 | ||||
| 2025-07-17 | 2025-07-16 | 4 | George Simeon See Note 2 | CRSP | Common Shares | I | 52,0300 | 22 319 | 1 161 | 238 897 | ||||
| 2025-07-17 | 2025-07-16 | 4 | George Simeon See Note 1 | CRSP | Common Shares | I | 52,0300 | 6 510 | 339 | 69 687 | ||||
| 2025-06-10 | 3/A | Morrison Briggs | CRSP | Common Shares | D | 5 209 | ||||||||
| 2025-05-30 | 2025-05-29 | 4 | Patel Naimish | CRSP | Common Shares | D | 35,9400 | −3 932 | −141 | 6 068 | ||||
| 2025-05-30 | 2025-05-28 | 4 | Patel Naimish | CRSP | Common Shares | D | 10 000 | 10 000 | ||||||
| 2025-03-24 | 2025-03-21 | 4 | Prasad Raju | CRSP | Common Shares | D | 41,2300 | −2 197 | −91 | 16 767 | ||||
| 2025-03-24 | 2025-03-20 | 4 | Prasad Raju | CRSP | Common Shares | D | 6 250 | 18 964 | ||||||
| 2025-03-24 | 2025-03-21 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 41,2300 | −3 185 | −131 | 81 729 | ||||
| 2025-03-24 | 2025-03-20 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 6 250 | 84 914 | ||||||
| 2025-03-24 | 2025-03-21 | 4 | Bruno Julianne | CRSP | Common Shares | D | 41,2300 | −1 714 | −71 | 10 544 | ||||
| 2025-03-24 | 2025-03-20 | 4 | Bruno Julianne | CRSP | Common Shares | D | 3 750 | 12 258 | ||||||
| 2025-03-24 | 2025-03-21 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 41,2300 | −10 031 | −414 | 195 085 | ||||
| 2025-03-24 | 2025-03-20 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19 688 | 205 116 | ||||||
| 2025-03-18 | 2025-03-17 | 4 | Prasad Raju | CRSP | Common Shares | D | 41,8000 | −3 762 | −157 | 12 714 | ||||
| 2025-03-18 | 2025-03-14 | 4 | Prasad Raju | CRSP | Common Shares | D | 10 000 | 16 476 | ||||||
| 2025-03-12 | 2025-03-12 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 43,3200 | −1 116 | −48 | 78 664 | ||||
| 2025-03-12 | 2025-03-11 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 2 250 | 79 780 | ||||||
| 2025-03-12 | 2025-03-11 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 42,4200 | −2 850 | −121 | 77 530 | ||||
| 2025-03-12 | 2025-03-10 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 5 500 | 80 380 | ||||||
| 2025-03-12 | 2025-03-12 | 4 | Bruno Julianne | CRSP | Common Shares | D | 43,3200 | −190 | −8 | 8 508 | ||||
| 2025-03-12 | 2025-03-11 | 4 | Bruno Julianne | CRSP | Common Shares | D | 435 | 8 698 | ||||||
| 2025-03-12 | 2025-03-11 | 4 | Bruno Julianne | CRSP | Common Shares | D | 42,4200 | −1 198 | −51 | 8 263 | ||||
| 2025-03-12 | 2025-03-10 | 4 | Bruno Julianne | CRSP | Common Shares | D | 2 399 | 9 461 | ||||||
| 2025-03-12 | 2025-03-12 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 43,3200 | −4 462 | −193 | 185 428 | ||||
| 2025-03-12 | 2025-03-11 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 9 000 | 189 890 | ||||||
| 2025-03-12 | 2025-03-11 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 42,4200 | −9 973 | −423 | 180 890 | ||||
| 2025-03-12 | 2025-03-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19 250 | 190 863 | ||||||
| 2025-02-28 | 2025-02-26 | 4 | Greene John | CRSP | Common Shares | D | 44,8497 | 7 000 | 314 | 7 000 | ||||
| 2025-02-21 | 2025-02-19 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 55,2050 | −18 360 | −1 014 | 171 613 | ||||
| 2025-02-19 | 2025-02-19 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 52,8000 | −6 928 | −366 | 189 973 | ||||
| 2025-02-19 | 2025-02-18 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 55,0500 | −11 640 | −641 | 196 901 | ||||
| 2025-02-19 | 2025-02-18 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 13 250 | 208 541 | ||||||
| 2025-02-19 | 2025-02-19 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 52,8000 | −1 947 | −103 | 74 880 | ||||
| 2025-02-19 | 2025-02-18 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 3 825 | 76 827 | ||||||
| 2025-02-19 | 2025-02-18 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 53,8500 | −9 595 | −517 | 73 002 | ||||
| 2025-02-19 | 2025-02-16 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 20 000 | 82 597 | ||||||
| 2025-02-19 | 2025-02-19 | 4 | Bruno Julianne | CRSP | Common Shares | D | 52,8000 | −333 | −18 | 7 062 | ||||
| 2025-02-19 | 2025-02-18 | 4 | Bruno Julianne | CRSP | Common Shares | D | 650 | 7 395 | ||||||
| 2024-12-27 | 2024-12-24 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 16,2100 | 13 751 | 223 | 195 291 | ||||
| 2024-12-04 | 2024-12-02 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 55,1043 | −15 000 | −827 | 181 540 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 56,2700 | −6 879 | −387 | 196 540 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 55,4300 | −23 121 | −1 282 | 203 419 | ||||
| 2024-10-15 | 2024-10-14 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 46,2800 | −4 293 | −199 | 226 540 | ||||
| 2024-10-15 | 2024-10-13 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 8 333 | 230 833 | ||||||
| 2024-10-15 | 2024-10-14 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 46,2800 | −1 089 | −50 | 62 597 | ||||
| 2024-10-15 | 2024-10-13 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 2 113 | 63 686 | ||||||
| 2024-08-12 | 2024-08-08 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | −100 000 | 222 500 | ||||||
| 2024-06-24 | 2024-06-21 | 4 | Bruno Julianne | CRSP | Common Shares | D | 56,0900 | −3 366 | −189 | 6 745 | ||||
| 2024-06-24 | 2024-06-20 | 4 | Bruno Julianne | CRSP | Common Shares | D | 7 000 | 10 111 | ||||||
| 2024-05-23 | 3 | Bruno Julianne By Julianne Bruno 2022 GRAT | CRSP | Common Shares | I | 7 088 | ||||||||
| 2024-05-23 | 3 | Bruno Julianne | CRSP | Common Shares | D | 3 111 | ||||||||
| 2024-04-17 | 2024-04-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 60,4003 | −1 204 | −73 | 208 122 | ||||
| 2024-04-17 | 2024-04-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 59,8819 | −18 378 | −1 101 | 209 326 | ||||
| 2024-04-17 | 2024-04-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 19 582 | 374 | 227 704 | ||||
| 2024-03-18 | 2024-03-15 | 4 | Prasad Raju | CRSP | Common Shares | D | 72,6900 | −3 524 | −256 | 6 476 | ||||
| 2024-03-18 | 2024-03-14 | 4 | Prasad Raju | CRSP | Common Shares | D | 10 000 | 10 000 | ||||||
| 2024-03-18 | 2024-03-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 73,0604 | −9 387 | −686 | 208 122 | ||||
| 2024-03-18 | 2024-03-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 71,9693 | −10 613 | −764 | 217 509 | ||||
| 2024-03-18 | 2024-03-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 20 000 | 382 | 228 122 | ||||
| 2024-03-12 | 2024-03-12 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 74,4400 | −4 583 | −341 | 208 122 | ||||
| 2024-03-12 | 2024-03-11 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 9 000 | 212 705 | ||||||
| 2024-03-12 | 2024-03-11 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 78,2600 | −9 802 | −767 | 203 705 | ||||
| 2024-03-12 | 2024-03-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19 250 | 213 507 | ||||||
| 2024-03-12 | 2024-03-12 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 74,4400 | −1 146 | −85 | 61 174 | ||||
| 2024-03-12 | 2024-03-11 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 2 250 | 62 320 | ||||||
| 2024-03-12 | 2024-03-11 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 78,2600 | −2 801 | −219 | 60 070 | ||||
| 2024-03-12 | 2024-03-10 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 5 500 | 62 871 | ||||||
| 2024-02-27 | 2024-02-27 | 4 | George Simeon See Note 3 | CRSP | Common Shares | I | 71,5000 | 769 196 | 54 998 | 769 196 | ||||
| 2024-02-27 | 2024-02-27 | 4 | George Simeon See Note 2 | CRSP | Common Shares | I | 71,5000 | 216 578 | 15 485 | 216 578 | ||||
| 2024-02-27 | 2024-02-27 | 4 | George Simeon See Note 1 | CRSP | Common Shares | I | 71,5000 | 63 177 | 4 517 | 63 177 | ||||
| 2024-02-21 | 2024-02-20 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 79,6700 | −6 370 | −507 | 194 257 | ||||
| 2024-02-21 | 2024-02-18 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 13 250 | 200 627 | ||||||
| 2024-02-21 | 2024-02-20 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 79,6700 | −1 913 | −152 | 57 371 | ||||
| 2024-02-21 | 2024-02-18 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 3 825 | 59 284 | ||||||
| 2024-02-16 | 2024-02-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 81,6645 | −1 100 | −90 | 187 377 | ||||
| 2024-02-16 | 2024-02-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 81,0379 | −5 951 | −482 | 188 477 | ||||
| 2024-02-16 | 2024-02-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 79,9359 | −12 949 | −1 035 | 194 428 | ||||
| 2024-02-16 | 2024-02-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 20 000 | 382 | 207 377 | ||||
| 2024-01-31 | 2024-01-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 61,0998 | −700 | −43 | 187 377 | ||||
| 2024-01-31 | 2024-01-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 60,5031 | −49 300 | −2 983 | 188 077 | ||||
| 2024-01-31 | 2024-01-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 50 000 | 956 | 237 377 | ||||
| 2024-01-18 | 2024-01-16 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 62,5029 | −20 000 | −1 250 | 187 377 | ||||
| 2024-01-18 | 2024-01-16 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 20 000 | 382 | 207 377 | ||||
| 2023-06-01 | 2023-05-30 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 66,8338 | −2 400 | −160 | 387 377 | ||||
| 2023-06-01 | 2023-05-30 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 65,6300 | −9 300 | −610 | 389 777 | ||||
| 2023-06-01 | 2023-05-30 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 64,4577 | −5 999 | −387 | 399 077 | ||||
| 2023-06-01 | 2023-05-30 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 63,6149 | −7 301 | −464 | 405 076 | ||||
| 2023-06-01 | 2023-05-30 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 25 000 | 478 | 412 377 | ||||
| 2023-05-25 | 2023-05-24 | 4 | Morrow Phuong Khanh | CRSP | Common Shares | D | 65,9100 | −2 527 | −167 | 4 411 | ||||
| 2023-05-25 | 2023-05-23 | 4 | Morrow Phuong Khanh | CRSP | Common Shares | D | 6 938 | 6 938 | ||||||
| 2023-04-27 | 2023-04-25 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 51,4503 | −4 393 | −226 | 387 377 | ||||
| 2023-04-27 | 2023-04-25 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 50,4982 | −20 607 | −1 041 | 391 770 | ||||
| 2023-04-27 | 2023-04-25 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 25 000 | 478 | 412 377 | ||||
| 2023-03-31 | 2023-03-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 44,7844 | −5 281 | −237 | 387 377 | ||||
| 2023-03-31 | 2023-03-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 44,3733 | −19 719 | −875 | 392 658 | ||||
| 2023-03-31 | 2023-03-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 25 000 | 478 | 412 377 | ||||
| 2023-03-14 | 2023-03-13 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 43,2200 | −4 086 | −177 | 387 377 | ||||
| 2023-03-14 | 2023-03-13 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 43,2200 | −5 358 | −232 | 382 463 | ||||
| 2023-03-14 | 2023-03-11 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 9 000 | 391 463 | ||||||
| 2023-03-14 | 2023-03-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 11 833 | 387 821 | ||||||
| 2023-03-14 | 2023-03-13 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 43,2200 | −1 022 | −44 | 54 844 | ||||
| 2023-03-14 | 2023-03-13 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 43,2200 | −1 283 | −55 | 53 616 | ||||
| 2023-03-14 | 2023-03-11 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 2 250 | 55 866 | ||||||
| 2023-03-14 | 2023-03-10 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 2 833 | 54 899 | ||||||
| 2023-03-01 | 2023-02-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 49,1986 | −1 100 | −54 | 375 988 | ||||
| 2023-03-01 | 2023-02-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 48,5725 | −13 720 | −666 | 377 088 | ||||
| 2023-03-01 | 2023-02-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 47,7122 | −10 180 | −486 | 390 808 | ||||
| 2023-03-01 | 2023-02-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 25 000 | 478 | 400 988 | ||||
| 2023-02-22 | 2023-02-21 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 48,2600 | −1 950 | −94 | 52 066 | ||||
| 2023-02-22 | 2023-02-18 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 3 825 | 54 016 | ||||||
| 2023-02-22 | 2023-02-21 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 48,2600 | −6 373 | −308 | 375 988 | ||||
| 2023-02-22 | 2023-02-18 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 13 250 | 382 361 | ||||||
| 2023-02-22 | 2023-02-21 | 4 | Smith Brendan | CRSP | Common Shares | D | 48,2600 | −1 392 | −67 | 5 072 | ||||
| 2023-02-22 | 2023-02-18 | 4 | Smith Brendan | CRSP | Common Shares | D | 3 825 | 6 464 | ||||||
| 2023-01-31 | 2023-01-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 51,5393 | −23 200 | −1 196 | 369 111 | ||||
| 2023-01-31 | 2023-01-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 50,6032 | −1 800 | −91 | 392 311 | ||||
| 2023-01-31 | 2023-01-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 25 000 | 478 | 394 111 | ||||
| 2022-12-30 | 2022-12-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 41,4546 | −4 634 | −192 | 369 111 | ||||
| 2022-12-30 | 2022-12-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 40,8126 | −20 366 | −831 | 373 745 | ||||
| 2022-12-30 | 2022-12-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 25 000 | 478 | 394 111 | ||||
| 2022-12-08 | 2022-12-06 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 58 233 | 105 | 369 111 | ||||
| 2022-12-06 | 2022-12-05 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 52,2600 | −19 401 | −1 014 | 310 878 | ||||
| 2022-12-06 | 2022-12-03 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 40 000 | 330 279 | ||||||
| 2022-12-06 | 2022-12-05 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 52,2600 | −3 234 | −169 | 50 191 | ||||
| 2022-12-06 | 2022-12-03 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 6 667 | 53 425 | ||||||
| 2022-11-30 | 2022-11-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 55,4039 | −2 310 | −128 | 290 279 | ||||
| 2022-11-30 | 2022-11-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 54,8453 | −5 572 | −306 | 292 589 | ||||
| 2022-11-30 | 2022-11-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 53,5837 | −17 118 | −917 | 298 161 | ||||
| 2022-11-30 | 2022-11-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 25 000 | 478 | 315 279 | ||||
| 2022-10-28 | 2022-10-26 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 55,6946 | −7 188 | −400 | 290 279 | ||||
| 2022-10-28 | 2022-10-26 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 54,9659 | −11 312 | −622 | 297 467 | ||||
| 2022-10-28 | 2022-10-26 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 54,0635 | −4 000 | −216 | 308 779 | ||||
| 2022-10-28 | 2022-10-26 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 52,7320 | −2 500 | −132 | 312 779 | ||||
| 2022-10-28 | 2022-10-26 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 19,1200 | 5 418 | 104 | 315 279 | ||||
| 2022-10-28 | 2022-10-26 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 16,2100 | 19 582 | 317 | 309 861 | ||||
| 2022-10-18 | 2022-10-17 | 4 | Smith Brendan | CRSP | Common Shares | D | 55,7600 | −1 111 | −62 | 2 639 | ||||
| 2022-10-18 | 2022-10-14 | 4 | Smith Brendan | CRSP | Common Shares | D | 3 750 | 3 750 | ||||||
| 2022-09-30 | 2022-09-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 64,9700 | −1 800 | −117 | 290 279 | ||||
| 2022-09-30 | 2022-09-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 64,5782 | −23 200 | −1 498 | 292 079 | ||||
| 2022-09-30 | 2022-09-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 16,2100 | 25 000 | 405 | 315 279 | ||||
| 2022-08-31 | 2022-08-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 67,6400 | −163 | −11 | 290 279 | ||||
| 2022-08-31 | 2022-08-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 66,9750 | −20 764 | −1 391 | 290 442 | ||||
| 2022-08-31 | 2022-08-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 66,1405 | −4 073 | −269 | 311 206 | ||||
| 2022-08-31 | 2022-08-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 16,2100 | 25 000 | 405 | 315 279 | ||||
| 2022-07-29 | 2022-07-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 77,9717 | −600 | −47 | 290 279 | ||||
| 2022-07-29 | 2022-07-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 76,2944 | −3 308 | −252 | 290 879 | ||||
| 2022-07-29 | 2022-07-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 75,7320 | −12 759 | −966 | 294 187 | ||||
| 2022-07-29 | 2022-07-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 77,7929 | −700 | −54 | 306 946 | ||||
| 2022-07-29 | 2022-07-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 76,3730 | −700 | −53 | 307 646 | ||||
| 2022-07-29 | 2022-07-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 75,6385 | −6 933 | −524 | 308 346 | ||||
| 2022-07-29 | 2022-07-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 16,2100 | 16 667 | 270 | 315 279 | ||||
| 2022-07-29 | 2022-07-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 12,5700 | 8 333 | 105 | 298 612 | ||||
| 2022-07-01 | 2022-06-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 62,3222 | −4 740 | −295 | 290 279 | ||||
| 2022-07-01 | 2022-06-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 61,4242 | −20 260 | −1 244 | 295 019 | ||||
| 2022-07-01 | 2022-06-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 12,5700 | 25 000 | 314 | 315 279 | ||||
| 2022-05-24 | 2022-05-23 | 4 | Morrow Phuong Khanh | CRSP | Stock Option (Right to Buy) | D | 54,71 | 90 000 | 90 000 | |||||
| 2022-05-24 | 2022-05-23 | 4 | Morrow Phuong Khanh | CRSP | Restricted Stock Units | D | 27 750 | 27 750 | ||||||
| 2022-03-14 | 2022-03-14 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 61,0800 | −4 153 | −254 | 290 279 | ||||
| 2022-03-14 | 2022-03-11 | 4 | Kulkarni Samarth | CRSP | Restricted Stock Units | D | −9 000 | 27 000 | ||||||
| 2022-03-14 | 2022-03-11 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 9 000 | 294 432 | ||||||
| 2022-03-14 | 2022-03-11 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 62,5600 | −5 487 | −343 | 285 432 | ||||
| 2022-03-14 | 2022-03-10 | 4 | Kulkarni Samarth | CRSP | Restricted Stock Units | D | −11 834 | 11 833 | ||||||
| 2022-03-14 | 2022-03-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 11 834 | 290 919 | ||||||
| 2022-03-14 | 2022-03-14 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 61,0800 | −1 229 | −75 | 26 797 | ||||
| 2022-03-14 | 2022-03-11 | 4 | Klein Lawrence Otto | CRSP | Restricted Stock Units | D | −3 000 | 9 000 | ||||||
| 2022-03-14 | 2022-03-11 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 3 000 | 28 026 | ||||||
| 2022-03-14 | 2022-03-11 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 62,5600 | −1 883 | −118 | 25 026 | ||||
| 2022-03-14 | 2022-03-10 | 4 | Klein Lawrence Otto | CRSP | Restricted Stock Units | D | −4 584 | 4 583 | ||||||
| 2022-03-14 | 2022-03-10 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 4 584 | 26 909 | ||||||
| 2022-03-14 | 2022-03-14 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 61,0800 | −1 039 | −63 | 46 429 | ||||
| 2022-03-14 | 2022-03-11 | 4 | KASINGER JAMES R. | CRSP | Restricted Stock Units | D | −2 250 | 6 750 | ||||||
| 2022-03-14 | 2022-03-11 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 2 250 | 47 468 | ||||||
| 2022-03-14 | 2022-03-11 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 62,5600 | −1 321 | −83 | 45 218 | ||||
| 2022-03-14 | 2022-03-10 | 4 | KASINGER JAMES R. | CRSP | Restricted Stock Units | D | −2 834 | 2 833 | ||||||
| 2022-03-14 | 2022-03-10 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 2 834 | 46 539 | ||||||
| 2022-02-22 | 2022-02-18 | 4 | Smith Brendan | CRSP | Restricted Stock Units | D | 15 300 | 15 300 | ||||||
| 2022-02-22 | 2022-02-18 | 4 | Smith Brendan | CRSP | Stock Option (Right to Buy) | D | 58,29 | 30 000 | 30 000 | |||||
| 2022-02-22 | 2022-02-18 | 4 | Kulkarni Samarth | CRSP | Restricted Stock Units | D | 53 000 | 53 000 | ||||||
| 2022-02-22 | 2022-02-18 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 58,29 | 115 000 | 115 000 | |||||
| 2022-02-22 | 2022-02-18 | 4 | Klein Lawrence Otto | CRSP | Restricted Stock Units | D | 20 400 | 20 400 | ||||||
| 2022-02-22 | 2022-02-18 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 58,29 | 46 200 | 46 200 | |||||
| 2022-02-22 | 2022-02-18 | 4 | KASINGER JAMES R. | CRSP | Restricted Stock Units | D | 15 300 | 15 300 | ||||||
| 2022-02-22 | 2022-02-18 | 4 | KASINGER JAMES R. | CRSP | Stock Option (Right to Buy) | D | 58,29 | 34 200 | 34 200 | |||||
| 2021-12-22 | 2021-12-20 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 1,81 | −17 750 | 58 233 | |||||
| 2021-12-22 | 2021-12-20 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 17 750 | 32 | 279 085 | ||||
| 2021-12-07 | 2021-12-06 | 4 | Ho Tony W | CRSP | Common Shares | D | 69,1700 | −12 607 | −872 | 52 364 | ||||
| 2021-12-07 | 2021-12-03 | 4 | Ho Tony W | CRSP | Restricted Stock Units | D | 26 667 | 13 333 | ||||||
| 2021-12-07 | 2021-12-03 | 4 | Ho Tony W | CRSP | Common Shares | D | 26 667 | 64 971 | ||||||
| 2021-12-07 | 2021-12-06 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 69,1700 | −6 303 | −436 | 43 542 | ||||
| 2021-12-07 | 2021-12-03 | 4 | KASINGER JAMES R. | CRSP | Restricted Stock Units | D | 13 333 | 6 667 | ||||||
| 2021-12-07 | 2021-12-03 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 13 333 | 49 845 | ||||||
| 2021-12-07 | 2021-12-06 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 69,1700 | −37 818 | −2 616 | 261 335 | ||||
| 2021-12-07 | 2021-12-03 | 4 | Kulkarni Samarth | CRSP | Restricted Stock Units | D | 80 000 | 40 000 | ||||||
| 2021-12-07 | 2021-12-03 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 80 000 | 299 153 | ||||||
| 2021-12-07 | 2021-12-06 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 69,1700 | −11 185 | −774 | 22 325 | ||||
| 2021-12-07 | 2021-12-03 | 4 | Klein Lawrence Otto | CRSP | Restricted Stock Units | D | 26 667 | 13 333 | ||||||
| 2021-12-07 | 2021-12-03 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 26 667 | 33 510 | ||||||
| 2021-12-03 | 2021-12-02 | 4 | KASINGER JAMES R. | CRSP | Stock Option (Right to Buy) | D | 13,62 | −7 342 | 93 632 | |||||
| 2021-12-03 | 2021-12-02 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 13,6200 | 7 342 | 100 | 36 512 | ||||
| 2021-12-03 | 2021-12-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 75,1000 | −779 | −59 | 219 153 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 1,81 | −33 000 | 75 983 | |||||
| 2021-10-18 | 2021-10-15 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 97,00 | 43 000 | 43 000 | |||||
| 2021-10-18 | 2021-10-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 33 000 | 60 | 219 932 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 97,00 | 13 800 | 13 800 | |||||
| 2021-10-18 | 2021-10-14 | 4 | Smith Brendan | CRSP | Stock Option (Right to Buy) | D | 98,70 | 90 000 | 90 000 | |||||
| 2021-10-18 | 2021-10-14 | 4 | Smith Brendan | CRSP | Restricted Stock Units | D | 15 000 | 15 000 | ||||||
| 2021-10-18 | 2021-10-15 | 4 | Ho Tony W | CRSP | Stock Option (Right to Buy) | D | 97,00 | 13 800 | 13 800 | |||||
| 2021-10-18 | 2021-10-15 | 4 | KASINGER JAMES R. | CRSP | Stock Option (Right to Buy) | D | 97,00 | 10 800 | 10 800 | |||||
| 2021-09-14 | 2021-09-13 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 117,8600 | −4 741 | −559 | 29 170 | ||||
| 2021-09-14 | 2021-09-10 | 4 | KASINGER JAMES R. | CRSP | Restricted Stock Units | D | −10 000 | 0 | ||||||
| 2021-09-14 | 2021-09-10 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 10 000 | 33 911 | ||||||
| 2021-09-14 | 2021-09-13 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 117,8600 | −4 207 | −496 | 6 843 | ||||
| 2021-09-14 | 2021-09-10 | 4 | Klein Lawrence Otto | CRSP | Restricted Stock Units | D | −10 000 | 0 | ||||||
| 2021-09-14 | 2021-09-10 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 10 000 | 11 050 | ||||||
| 2021-09-03 | 2021-09-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 124,8300 | −787 | −98 | 186 932 | ||||
| 2021-08-10 | 2021-08-06 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 139,4600 | −5 989 | −835 | 1 891 | ||||
| 2021-08-10 | 2021-08-06 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 138,2200 | −19 011 | −2 628 | 7 880 | ||||
| 2021-08-10 | 2021-08-06 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 17,7500 | 25 000 | 444 | 26 891 | ||||
| 2021-08-10 | 2021-03-11 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Stock Option (Right to Buy) | D | 17,75 | −25 000 | 131 000 | |||||
| 2021-08-06 | 2021-08-05 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 12,57 | −28 500 | 33 333 | |||||
| 2021-08-06 | 2021-08-05 | 4 | Kulkarni Samarth | CRSP | Common Stock | D | 130,5100 | −2 482 | −324 | 187 719 | ||||
| 2021-08-06 | 2021-08-05 | 4 | Kulkarni Samarth | CRSP | Common Stock | D | 129,8200 | −6 819 | −885 | 190 201 | ||||
| 2021-08-06 | 2021-08-05 | 4 | Kulkarni Samarth | CRSP | Common Stock | D | 128,8500 | −13 499 | −1 739 | 197 020 | ||||
| 2021-08-06 | 2021-08-05 | 4 | Kulkarni Samarth | CRSP | Common Stock | D | 127,8200 | −4 700 | −601 | 210 519 | ||||
| 2021-08-06 | 2021-08-05 | 4 | Kulkarni Samarth | CRSP | Common Stock | D | 126,6700 | −1 000 | −127 | 215 219 | ||||
| 2021-08-06 | 2021-08-05 | 4 | Kulkarni Samarth | CRSP | Common Stock | D | 12,5700 | 28 500 | 358 | 216 219 | ||||
| 2021-08-06 | 2021-08-04 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 12,57 | −1 500 | 61 833 | |||||
| 2021-08-06 | 2021-08-04 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 125,0200 | −1 500 | −188 | 187 719 | ||||
| 2021-08-06 | 2021-08-04 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 12,5700 | 1 500 | 19 | 189 219 | ||||
| 2021-07-21 | 2021-07-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 128,7057 | −700 | −90 | 148 831 | ||||
| 2021-07-21 | 2021-07-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 127,3560 | −1 324 | −169 | 149 531 | ||||
| 2021-07-21 | 2021-07-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 126,4063 | −4 472 | −565 | 150 855 | ||||
| 2021-07-21 | 2021-07-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 125,6693 | −3 504 | −440 | 155 327 | ||||
| 2021-07-01 | 2021-06-30 | 4 | Novak Rodger | CRSP | Common Shares | D | 165,0000 | −25 000 | −4 125 | 573 007 | ||||
| 2021-06-30 | 2021-06-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 152,4217 | −1 200 | −183 | 0 | ||||
| 2021-06-30 | 2021-06-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 151,2431 | −6 646 | −1 005 | 1 200 | ||||
| 2021-06-30 | 2021-06-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 150,4930 | −12 753 | −1 919 | 7 846 | ||||
| 2021-06-30 | 2021-06-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 149,4694 | −7 981 | −1 193 | 20 599 | ||||
| 2021-06-30 | 2021-06-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 148,5788 | −12 176 | −1 809 | 28 580 | ||||
| 2021-06-30 | 2021-06-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 147,4321 | −4 780 | −705 | 40 756 | ||||
| 2021-06-30 | 2021-06-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 146,6933 | −600 | −88 | 45 536 | ||||
| 2021-06-30 | 2021-06-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 145,9171 | −1 400 | −204 | 46 136 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 847 | 47 536 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −6 018 | 0 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 6 018 | 6 018 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −27 861 | 16 434 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 18 973 | 46 689 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −84 085 | 0 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 2 633 | 84 085 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −12 189 | 6 268 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 2 378 | 81 452 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −11 011 | 5 614 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 79 074 | 79 074 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −366 084 | 215 915 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −3 650 | 622 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 27 716 | 27 716 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −158 522 | 0 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 158 522 | 158 522 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −615 607 | 104 874 | ||||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 156,5414 | −269 | −42 | 158 831 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 156,5414 | −549 | −86 | 0 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 155,2725 | −132 | −20 | 159 100 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 155,2725 | −268 | −42 | 549 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 154,5656 | −1 119 | −173 | 159 232 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 154,5656 | −2 281 | −353 | 817 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 153,5389 | −2 218 | −341 | 160 351 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 153,5389 | −4 519 | −694 | 3 098 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 152,3763 | −1 540 | −235 | 162 569 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 152,3763 | −3 139 | −478 | 7 617 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 151,4949 | −3 144 | −476 | 164 109 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 151,4949 | −6 403 | −970 | 10 756 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 150,6503 | −1 578 | −238 | 167 253 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 150,6503 | −3 216 | −484 | 17 159 | ||||
| 2021-06-30 | 2021-06-28 | 4 | Novak Rodger | CRSP | Common Shares | D | 156,5500 | −25 000 | −3 914 | 598 007 | ||||
| 2021-06-23 | 2021-06-21 | 4 | Novak Rodger | CRSP | Common Shares | D | 130,2700 | −50 | −7 | 623 007 | ||||
| 2021-06-23 | 2021-06-21 | 4 | Novak Rodger | CRSP | Common Shares | D | 129,4600 | −7 299 | −945 | 623 057 | ||||
| 2021-06-23 | 2021-06-21 | 4 | Novak Rodger | CRSP | Common Shares | D | 128,7600 | −12 630 | −1 626 | 630 356 | ||||
| 2021-06-23 | 2021-06-21 | 4 | Novak Rodger | CRSP | Common Shares | D | 127,7100 | −2 969 | −379 | 642 986 | ||||
| 2021-06-23 | 2021-06-21 | 4 | Novak Rodger | CRSP | Common Shares | D | 126,6200 | −881 | −112 | 645 955 | ||||
| 2021-06-23 | 2021-06-21 | 4 | Novak Rodger | CRSP | Common Shares | D | 125,5800 | −1 171 | −147 | 646 836 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 12,57 | −30 000 | 63 333 | |||||
| 2021-06-17 | 2021-06-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 127,5100 | −3 488 | −445 | 187 719 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 126,8600 | −16 129 | −2 046 | 191 207 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 125,3900 | −10 383 | −1 302 | 207 336 | ||||
| 2021-06-17 | 2021-06-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 12,5700 | 30 000 | 377 | 217 719 | ||||
| 2021-06-15 | 2021-06-11 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 129,4472 | −755 | −98 | 20 375 | ||||
| 2021-06-15 | 2021-06-11 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 128,6518 | −1 100 | −142 | 21 130 | ||||
| 2021-06-15 | 2021-06-11 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 127,8838 | −800 | −102 | 22 230 | ||||
| 2021-06-15 | 2021-06-11 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 126,5946 | −1 918 | −243 | 23 030 | ||||
| 2021-06-15 | 2021-06-11 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 125,6225 | −5 427 | −682 | 24 948 | ||||
| 2021-06-14 | 2021-06-10 | 4 | Behbahani Ali | CRSP | Stock Option (Right to Buy) | D | 123,71 | 10 000 | 10 000 | |||||
| 2021-06-14 | 2021-06-10 | 4 | Treco Douglas A | CRSP | Stock Option (Right to Buy) | D | 123,71 | 10 000 | 10 000 | |||||
| 2021-06-14 | 2021-06-10 | 4 | High Katherine A | CRSP | Stock Option (Right to Buy) | D | 123,71 | 10 000 | 10 000 | |||||
| 2021-06-14 | 2021-06-10 | 4 | Greene John | CRSP | Stock Option (Right to Buy) | D | 123,71 | 10 000 | 10 000 | |||||
| 2021-06-14 | 2021-06-10 | 4 | George Simeon | CRSP | Stock Option (Right to Buy) | D | 123,71 | 10 000 | 10 000 | |||||
| 2021-06-14 | 2021-06-10 | 4 | Bolzon Bradley J PhD | CRSP | Stock Option (Right to Buy) | D | 123,71 | 10 000 | 10 000 | |||||
| 2021-06-14 | 2021-06-10 | 4 | Fleming Harold Edward | CRSP | Stock Option (Right to Buy) | D | 123,71 | 25 000 | 25 000 | |||||
| 2021-06-03 | 2021-06-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 115,8000 | −779 | −90 | 187 719 | ||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 44,67 | −12 000 | 43 000 | |||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 14,43 | −12 000 | 43 000 | |||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 40,87 | −20 000 | 25 000 | |||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 29,87 | −10 000 | 10 000 | |||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 51,49 | −22 000 | 38 000 | |||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 17,66 | −12 000 | 3 000 | |||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 126,9700 | −12 000 | −1 524 | 1 050 | ||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 128,2000 | −88 000 | −11 282 | 13 050 | ||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 17,6600 | 12 000 | 212 | 101 050 | ||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 14,4300 | 12 000 | 173 | 89 050 | ||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 40,8700 | 20 000 | 817 | 77 050 | ||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 29,8700 | 10 000 | 299 | 57 050 | ||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 51,4900 | 22 000 | 1 133 | 47 050 | ||||
| 2021-03-25 | 2021-03-23 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 44,6700 | 12 000 | 536 | 25 050 | ||||
| 2021-03-24 | 2021-03-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 134,9267 | −300 | −40 | 30 375 | ||||
| 2021-03-24 | 2021-03-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 134,3317 | −5 237 | −703 | 30 675 | ||||
| 2021-03-24 | 2021-03-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 133,2837 | −9 334 | −1 244 | 35 912 | ||||
| 2021-03-24 | 2021-03-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 132,5275 | −6 090 | −807 | 45 246 | ||||
| 2021-03-24 | 2021-03-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 131,1422 | −2 400 | −315 | 51 336 | ||||
| 2021-03-24 | 2021-03-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 130,4166 | −3 413 | −445 | 53 736 | ||||
| 2021-03-24 | 2021-03-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 129,3550 | −3 600 | −466 | 57 149 | ||||
| 2021-03-12 | 2021-03-11 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Restricted Stock Units | D | 9 000 | 9 000 | ||||||
| 2021-03-12 | 2021-03-11 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Stock Option (Right to Buy) | D | 133,88 | 25 360 | 25 360 | |||||
| 2021-03-12 | 2021-03-10 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 124,1500 | −1 352 | −168 | 1 891 | ||||
| 2021-03-12 | 2021-03-10 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 2 833 | 3 243 | ||||||
| 2021-03-12 | 2021-03-11 | 4 | Kulkarni Samarth | CRSP | Restricted Stock Units | D | 36 000 | 36 000 | ||||||
| 2021-03-12 | 2021-03-11 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 133,88 | 100 000 | 100 000 | |||||
| 2021-03-12 | 2021-03-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 124,1500 | −5 526 | −686 | 188 498 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 11 833 | 194 024 | ||||||
| 2021-03-12 | 2021-03-11 | 4 | Klein Lawrence Otto | CRSP | Restricted Stock Units | D | 12 000 | 12 000 | ||||||
| 2021-03-12 | 2021-03-11 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 133,88 | 33 334 | 33 334 | |||||
| 2021-03-12 | 2021-03-10 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 124,1500 | −2 141 | −266 | 13 050 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 4 583 | 15 191 | ||||||
| 2021-03-12 | 2021-03-11 | 4 | KASINGER JAMES R. | CRSP | Restricted Stock Units | D | 9 000 | 9 000 | ||||||
| 2021-03-12 | 2021-03-11 | 4 | KASINGER JAMES R. | CRSP | Stock Option (Right to Buy) | D | 133,88 | 25 360 | 25 360 | |||||
| 2021-03-12 | 2021-03-10 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 124,1500 | −1 353 | −168 | 23 911 | ||||
| 2021-03-12 | 2021-03-10 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 2 833 | 25 264 | ||||||
| 2021-03-12 | 2021-03-11 | 4 | Ho Tony W | CRSP | Restricted Stock Units | D | 9 000 | 9 000 | ||||||
| 2021-03-12 | 2021-03-11 | 4 | Ho Tony W | CRSP | Stock Option (Right to Buy) | D | 133,88 | 23 334 | 23 334 | |||||
| 2021-03-12 | 2021-03-10 | 4 | Ho Tony W | CRSP | Common Shares | D | 124,1500 | −2 141 | −266 | 38 304 | ||||
| 2021-03-12 | 2021-03-10 | 4 | Ho Tony W | CRSP | Common Shares | D | 4 583 | 40 445 | ||||||
| 2021-03-12 | 2021-01-15 | 4/A | Klein Lawrence Otto | CRSP | Common Shares | D | 14,4300 | 16 334 | 236 | 26 942 | ||||
| 2021-03-09 | 2021-03-05 | 4 | Ho Tony W | CRSP | Common Shares | D | 114,6500 | −1 585 | −182 | 35 862 | ||||
| 2021-03-09 | 2021-03-05 | 4 | Ho Tony W | CRSP | Common Shares | D | 3 333 | 37 447 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 565 | 60 749 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −4 012 | 0 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 4 012 | 4 012 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −18 574 | 44 295 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 12 648 | 60 184 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −56 056 | 0 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 1 755 | 56 056 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −8 126 | 18 457 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 1 585 | 54 301 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −7 341 | 16 625 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 52 716 | 52 716 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −244 056 | 581 999 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 130,2500 | −798 | −104 | 182 191 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 847 | 47 536 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −6 018 | 0 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 6 018 | 6 018 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −27 861 | 62 869 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 18 973 | 46 689 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −84 085 | 0 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 2 633 | 84 085 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −12 189 | 26 583 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 2 378 | 81 452 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −11 011 | 23 966 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 79 074 | 79 074 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −366 084 | 826 055 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −3 650 | 4 272 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 27 716 | 27 716 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −158 522 | 0 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 158 522 | 158 522 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −615 607 | 720 481 | ||||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 151,8198 | −3 463 | −526 | 168 831 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 150,9903 | −27 932 | −4 217 | 172 294 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 150,1042 | −38 132 | −5 724 | 200 226 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 149,2432 | −23 276 | −3 474 | 238 358 | ||||
| 2021-02-23 | 2021-02-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 147,7886 | −78 200 | −11 557 | 261 634 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 1,81 | −20 000 | 108 983 | |||||
| 2021-01-20 | 2021-01-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 217,4400 | −1 304 | −284 | 182 989 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 216,5000 | −1 708 | −370 | 184 293 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 214,6800 | −1 700 | −365 | 186 001 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 213,7100 | −5 623 | −1 202 | 187 701 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 212,7500 | −6 525 | −1 388 | 193 324 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 211,8300 | −3 140 | −665 | 199 849 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 20 000 | 36 | 202 989 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 14,43 | −16 334 | 14 666 | |||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 12,57 | −8 666 | 0 | |||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 219,9900 | −2 | −0 | 20 000 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 218,5400 | −701 | −153 | 20 002 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 217,4200 | −9 997 | −2 174 | 20 703 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 216,3900 | −1 500 | −325 | 30 700 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 214,6000 | −700 | −150 | 32 200 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 213,6400 | −2 800 | −598 | 32 900 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 212,2000 | −634 | −135 | 35 700 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 14,4300 | 16 344 | 236 | 36 334 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 217,4500 | −200 | −43 | 20 000 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 216,2400 | −400 | −86 | 20 200 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 214,4600 | −1 400 | −300 | 20 600 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 213,7100 | −1 200 | −256 | 22 000 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 212,5400 | −2 555 | −543 | 23 200 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 211,4400 | −2 911 | −616 | 25 755 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 12,5700 | 8 666 | 109 | 28 666 | ||||
| 2021-01-20 | 2021-01-19 | 4 | KASINGER JAMES R. | CRSP | Stock Option (right to buy) | D | 51,49 | −27 500 | 12 500 | |||||
| 2021-01-20 | 2021-01-19 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 207,6100 | −2 100 | −436 | 22 431 | ||||
| 2021-01-20 | 2021-01-19 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 206,0500 | −1 800 | −371 | 24 531 | ||||
| 2021-01-20 | 2021-01-19 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 205,6000 | −8 997 | −1 850 | 26 331 | ||||
| 2021-01-20 | 2021-01-19 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 204,4000 | −7 818 | −1 598 | 35 328 | ||||
| 2021-01-20 | 2021-01-19 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 203,5800 | −6 785 | −1 381 | 43 146 | ||||
| 2021-01-20 | 2021-01-19 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 51,4900 | 27 500 | 1 416 | 49 931 | ||||
| 2021-01-04 | 2021-01-02 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 153,1100 | −9 392 | −1 438 | 10 608 | ||||
| 2020-12-30 | 2020-12-29 | 4 | Kulkarni Samarth | CRSP | Stock Option (right to buy) | D | 1,81 | −13 800 | 128 983 | |||||
| 2020-12-30 | 2020-12-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 13 800 | 25 | 182 989 | ||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Stock Option (right to buy) | D | 16,90 | −23 551 | 236 449 | |||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Common Shares | D | 150,6100 | −2 951 | −444 | 33 964 | ||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Common Shares | D | 149,7300 | −5 000 | −749 | 36 915 | ||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Common Shares | D | 148,3800 | −8 400 | −1 246 | 41 915 | ||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Common Shares | D | 147,0500 | −1 400 | −206 | 50 315 | ||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Common Shares | D | 152,4100 | −500 | −76 | 51 715 | ||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Common Shares | D | 151,5800 | −1 100 | −167 | 52 215 | ||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Common Shares | D | 150,1600 | −1 600 | −240 | 53 315 | ||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Common Shares | D | 149,1800 | −900 | −134 | 54 915 | ||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Common Shares | D | 148,1100 | −1 700 | −252 | 55 815 | ||||
| 2020-12-22 | 2020-12-21 | 4 | Ho Tony W | CRSP | Common Shares | D | 16,9000 | 23 551 | 398 | 57 515 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 151,0474 | −931 | −141 | 339 834 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 151,0474 | −969 | −146 | 0 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 150,1432 | −958 | −144 | 340 765 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 150,1432 | −995 | −149 | 969 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 149,1222 | −2 009 | −300 | 341 723 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 149,1222 | −2 091 | −312 | 1 964 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 148,2811 | −2 576 | −382 | 343 732 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 148,2811 | −2 679 | −397 | 4 055 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 147,0020 | −878 | −129 | 346 308 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 147,0020 | −914 | −134 | 6 734 | ||||
| 2020-12-17 | 2020-12-10 | 4/A | Bolzon Bradley J PhD | CRSP | Common Shares | D | 144,8525 | −15 900 | −2 303 | 7 648 | ||||
| 2020-12-17 | 2020-12-10 | 4/A | Bolzon Bradley J PhD | CRSP | Common Shares | D | 143,2579 | −2 223 | −318 | 23 548 | ||||
| 2020-12-17 | 2020-12-10 | 4/A | Bolzon Bradley J PhD | CRSP | Common Shares | D | 142,4240 | −5 958 | −849 | 25 771 | ||||
| 2020-12-17 | 2020-12-10 | 4/A | Bolzon Bradley J PhD | CRSP | Common Shares | D | 141,5348 | −6 648 | −941 | 31 729 | ||||
| 2020-12-17 | 2020-12-10 | 4/A | Bolzon Bradley J PhD | CRSP | Common Shares | D | 140,6188 | −2 271 | −319 | 38 377 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 144,8525 | −15 900 | −2 303 | 314 186 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 143,2579 | −2 223 | −318 | 330 086 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 142,4240 | −5 958 | −849 | 332 309 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 141,5348 | −6 648 | −941 | 338 267 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 140,6188 | −2 271 | −319 | 344 915 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 1,81 | −20 000 | 142 783 | |||||
| 2020-12-11 | 2020-12-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 144,9700 | −600 | −87 | 169 189 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 143,7100 | −2 100 | −302 | 169 789 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 142,7500 | −6 766 | −966 | 171 889 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 141,9800 | −5 034 | −715 | 178 655 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 141,1700 | −5 500 | −776 | 183 689 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 20 000 | 36 | 189 189 | ||||
| 2020-12-10 | 2020-12-09 | 4 | KASINGER JAMES R. | CRSP | Stock Option (right to buy) | D | 13,62 | −22 026 | 100 974 | |||||
| 2020-12-10 | 2020-12-09 | 4 | KASINGER JAMES R. | CRSP | Common Shares | D | 13,6200 | 22 026 | 300 | 22 415 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 163,1313 | −800 | −131 | 347 186 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 162,4034 | −14 270 | −2 317 | 347 986 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 161,5719 | −17 627 | −2 848 | 362 256 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 160,4975 | −9 397 | −1 508 | 379 883 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 159,4791 | −8 453 | −1 348 | 389 280 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 158,4057 | −15 260 | −2 417 | 397 733 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 157,5383 | −8 582 | −1 352 | 412 993 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 156,5301 | −4 457 | −698 | 421 575 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 155,3594 | −12 123 | −1 883 | 426 032 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 154,4054 | −4 300 | −664 | 438 155 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 153,4396 | −10 098 | −1 549 | 442 455 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 151,3167 | −600 | −91 | 452 553 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 150,5712 | −7 067 | −1 064 | 453 153 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 149,4090 | −9 416 | −1 407 | 460 220 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 148,4475 | −12 703 | −1 886 | 469 636 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 147,4008 | −24 077 | −3 549 | 482 339 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 146,5660 | −4 203 | −616 | 506 416 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 145,4293 | −2 762 | −402 | 510 619 | ||||
| 2020-12-09 | 2020-12-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 144,3926 | −4 809 | −694 | 513 381 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 129,5800 | −779 | −101 | 169 189 | ||||
| 2020-12-02 | 2020-11-30 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,00 | −50 000 | 140 315 | |||||
| 2020-12-02 | 2020-11-30 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,43 | −50 000 | 140 315 | |||||
| 2020-12-02 | 2020-11-30 | 4 | Novak Rodger | CRSP | Common Shares | D | 125,0000 | −50 000 | −6 250 | 648 007 | ||||
| 2020-12-02 | 2020-11-30 | 4 | Novak Rodger | CRSP | Common Shares | D | 125,0000 | −50 000 | −6 250 | 648 007 | ||||
| 2020-12-02 | 2020-11-30 | 4 | Novak Rodger | CRSP | Common Shares | D | 14,4300 | 50 000 | 722 | 698 007 | ||||
| 2020-12-02 | 2020-11-30 | 4 | Novak Rodger | CRSP | Common Shares | D | 14,0000 | 50 000 | 700 | 698 007 | ||||
| 2020-11-02 | 2020-10-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 18 477 | 40 648 | ||||||
| 2020-11-02 | 2020-10-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −2 433 | 7 922 | ||||||
| 2020-11-02 | 2020-10-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −105 681 | 0 | ||||||
| 2020-11-02 | 2020-10-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 105 681 | 105 681 | ||||||
| 2020-11-02 | 2020-10-29 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −410 405 | 1 336 088 | ||||||
| 2020-10-13 | 2020-10-09 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,43 | −2 762 | 190 315 | |||||
| 2020-10-13 | 2020-10-09 | 4 | Novak Rodger | CRSP | Common Shares | D | 100,0000 | −2 762 | −276 | 648 007 | ||||
| 2020-10-13 | 2020-10-09 | 4 | Novak Rodger | CRSP | Common Shares | D | 14,4300 | 2 762 | 40 | 650 769 | ||||
| 2020-10-13 | 2020-10-08 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,43 | −22 238 | 193 077 | |||||
| 2020-10-13 | 2020-10-08 | 4 | Novak Rodger | CRSP | Common Shares | D | 100,0000 | −22 238 | −2 224 | 648 007 | ||||
| 2020-10-13 | 2020-10-08 | 4 | Novak Rodger | CRSP | Common Shares | D | 14,4300 | 22 238 | 321 | 670 245 | ||||
| 2020-10-06 | 2020-10-05 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Stock Option (Right to Buy) | D | 86,75 | 11 666 | 11 666 | |||||
| 2020-10-06 | 2020-10-05 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 86,75 | 47 333 | 47 333 | |||||
| 2020-10-06 | 2020-10-05 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 86,75 | 16 666 | 16 666 | |||||
| 2020-10-06 | 2020-10-05 | 4 | Ho Tony W | CRSP | Stock Option (Right to Buy) | D | 86,75 | 16 666 | 16 666 | |||||
| 2020-10-06 | 2020-10-05 | 4 | KASINGER JAMES R. | CRSP | Stock Option (Right to Buy) | D | 86,75 | 11 666 | 11 666 | |||||
| 2020-09-24 | 2020-09-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 14 780 | 22 171 | ||||||
| 2020-09-24 | 2020-09-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −1 948 | 10 355 | ||||||
| 2020-09-24 | 2020-09-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −84 544 | 0 | ||||||
| 2020-09-24 | 2020-09-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 84 544 | 84 544 | ||||||
| 2020-09-24 | 2020-09-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −328 324 | 1 746 493 | ||||||
| 2020-09-22 | 2020-09-18 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 86,8652 | −3 035 | −264 | 518 190 | ||||
| 2020-09-18 | 2020-09-16 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 86,9802 | −8 965 | −780 | 521 225 | ||||
| 2020-09-16 | 2020-09-14 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 84,8877 | −1 155 | −98 | 530 190 | ||||
| 2020-09-11 | 2020-09-10 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 85,8971 | −8 684 | −746 | 531 345 | ||||
| 2020-09-11 | 2020-09-10 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 85,0269 | −14 161 | −1 204 | 540 029 | ||||
| 2020-09-11 | 2020-09-09 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 7 391 | 7 391 | ||||||
| 2020-09-11 | 2020-09-09 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −42 272 | 0 | ||||||
| 2020-09-11 | 2020-09-09 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 42 272 | 42 272 | ||||||
| 2020-09-11 | 2020-09-09 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −974 | 12 303 | ||||||
| 2020-09-11 | 2020-09-09 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −164 162 | 2 074 817 | ||||||
| 2020-09-03 | 2020-09-01 | 4 | Bolzon Bradley J PhD See Footnotes | CRSP | Stock Option (Right to Buy) | I | 13,62 | −15 000 | 15 000 | |||||
| 2020-09-03 | 2020-09-01 | 4 | Bolzon Bradley J PhD See Footnotes | CRSP | Stock Option (Right to Buy) | I | 59,31 | −15 000 | 15 000 | |||||
| 2020-09-03 | 2020-09-01 | 4 | Bolzon Bradley J PhD See Footnotes | CRSP | Stock Option (Right to Buy) | I | 14,00 | −30 000 | 30 000 | |||||
| 2020-09-03 | 2020-09-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 93,7400 | −200 | −19 | 0 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 92,9844 | −19 135 | −1 779 | 200 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 92,4010 | −36 365 | −3 360 | 19 335 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 91,2738 | −4 300 | −392 | 55 700 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 59,3100 | 15 000 | 890 | 60 000 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 13,6200 | 15 000 | 204 | 45 000 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 14,0000 | 30 000 | 420 | 30 000 | ||||
| 2020-09-03 | 2020-09-01 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Stock Option (Right to Buy) | D | 17,75 | −12 000 | 156 000 | |||||
| 2020-09-03 | 2020-09-01 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 93,1800 | −2 800 | −261 | 410 | ||||
| 2020-09-03 | 2020-09-01 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 92,2300 | −6 400 | −590 | 3 210 | ||||
| 2020-09-03 | 2020-09-01 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 91,3900 | −2 800 | −256 | 9 610 | ||||
| 2020-09-03 | 2020-09-01 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 17,7500 | 12 000 | 213 | 12 410 | ||||
| 2020-09-03 | 2020-09-02 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 94,1500 | −779 | −73 | 169 968 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,43 | −21 067 | 215 315 | |||||
| 2020-09-03 | 2020-09-01 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,00 | −3 933 | 111 893 | |||||
| 2020-09-03 | 2020-09-01 | 4 | Novak Rodger | CRSP | Common Shares | D | 93,1900 | −3 840 | −358 | 648 007 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Novak Rodger | CRSP | Common Shares | D | 92,5900 | −19 754 | −1 829 | 651 847 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Novak Rodger | CRSP | Common Shares | D | 91,5400 | −1 406 | −129 | 671 601 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Novak Rodger | CRSP | Common Shares | D | 14,4300 | 21 067 | 304 | 673 007 | ||||
| 2020-09-03 | 2020-09-01 | 4 | Novak Rodger | CRSP | Common Shares | D | 14,0000 | 3 933 | 55 | 651 940 | ||||
| 2020-08-21 | 2020-08-19 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,00 | −25 000 | 115 826 | |||||
| 2020-08-21 | 2020-08-19 | 4 | Novak Rodger | CRSP | Common Shares | D | 100,0000 | −25 000 | −2 500 | 648 007 | ||||
| 2020-08-21 | 2020-08-19 | 4 | Novak Rodger | CRSP | Common Shares | D | 14,0000 | 25 000 | 350 | 673 007 | ||||
| 2020-08-14 | 2020-08-13 | 4 | Behbahani Ali See Note 3 | CRSP | Common Stock | I | 14 | 14 | ||||||
| 2020-08-14 | 2020-08-13 | 4 | Behbahani Ali | CRSP | Common Stock | D | 57 | 256 | ||||||
| 2020-08-05 | 2020-08-03 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 87,3330 | −5 448 | −476 | 410 | ||||
| 2020-08-05 | 2020-08-03 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 86,2528 | −6 552 | −565 | 5 858 | ||||
| 2020-08-05 | 2020-08-03 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Common Shares | D | 17,7500 | 12 000 | 213 | 12 410 | ||||
| 2020-08-05 | 2017-11-13 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Stock Option (Right to Buy) | D | 17,75 | −12 000 | 168 000 | |||||
| 2020-07-09 | 2020-07-07 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,00 | −19 414 | 140 826 | |||||
| 2020-07-09 | 2020-07-07 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 1,81 | −5 586 | 0 | |||||
| 2020-07-09 | 2020-07-07 | 4 | Novak Rodger | CRSP | Common Shares | D | 90,0000 | −25 000 | −2 250 | 648 007 | ||||
| 2020-07-09 | 2020-07-07 | 4 | Novak Rodger | CRSP | Common Shares | D | 14,0000 | 19 414 | 272 | 673 007 | ||||
| 2020-07-09 | 2020-07-07 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 5 586 | 10 | 653 593 | ||||
| 2020-07-08 | 2020-07-06 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 82,9994 | −5 311 | −441 | 554 190 | ||||
| 2020-07-08 | 2020-07-06 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 82,1649 | −14 689 | −1 207 | 559 501 | ||||
| 2020-07-06 | 2020-07-01 | 4 | Novak Rodger | CRSP | Common Shares | D | 80,0000 | −50 000 | −4 000 | 648 007 | ||||
| 2020-06-26 | 2020-06-25 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 12,57 | −4 912 | 8 666 | |||||
| 2020-06-26 | 2020-06-25 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 75,1776 | −4 912 | −369 | 20 000 | ||||
| 2020-06-26 | 2020-06-25 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 12,5700 | 4 912 | 62 | 24 912 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 12,57 | −26 422 | 13 578 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 5,86 | −38 666 | 0 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 76,2575 | −2 913 | −222 | 20 000 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 75,3227 | −12 175 | −917 | 22 913 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 76,5012 | −800 | −61 | 35 088 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 75,9370 | −3 934 | −299 | 35 888 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 74,8974 | −6 600 | −494 | 39 822 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 12,5700 | 26 422 | 332 | 46 422 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 76,5011 | −22 700 | −1 737 | 20 000 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 75,9279 | −15 966 | −1 212 | 42 700 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 5,8600 | 38 666 | 227 | 58 666 | ||||
| 2020-06-25 | 2020-06-23 | 4 | Novak Rodger | CRSP | Common Shares | D | 75,0000 | −50 000 | −3 750 | 698 007 | ||||
| 2020-06-24 | 2020-06-23 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 75,3453 | −10 000 | −753 | 574 190 | ||||
| 2020-06-24 | 2020-06-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 72,5069 | −10 000 | −725 | 584 190 | ||||
| 2020-06-24 | 2020-06-23 | 4 | Ho Tony W | CRSP | Common Shares | D | 75,2000 | −6 929 | −521 | 33 747 | ||||
| 2020-06-24 | 2020-06-22 | 4 | Ho Tony W | CRSP | Common Shares | D | 70,1400 | −229 | −16 | 40 676 | ||||
| 2020-06-15 | 2020-06-11 | 4 | Behbahani Ali | CRSP | Stock Option (Right to Buy) | D | 59,70 | 15 000 | 15 000 | |||||
| 2020-06-15 | 2020-06-11 | 4 | Treco Douglas A | CRSP | Stock Option (Right to Buy) | D | 59,70 | 30 000 | 30 000 | |||||
| 2020-06-15 | 2020-06-11 | 4 | High Katherine A | CRSP | Stock Option (Right to Buy) | D | 59,70 | 15 000 | 15 000 | |||||
| 2020-06-15 | 3 | Treco Douglas A | CRSP | Common Shares | D | 4 000 | ||||||||
| 2020-06-15 | 3 | Treco Douglas A | CRSP | Common Shares | D | 4 000 | ||||||||
| 2020-06-15 | 3 | Treco Douglas A | CRSP | Common Shares | D | 4 000 | ||||||||
| 2020-06-15 | 2020-06-11 | 4 | George Simeon | CRSP | Stock Option (Right to Buy) | D | 59,70 | 15 000 | 15 000 | |||||
| 2020-06-15 | 2020-06-11 | 4 | Greene John | CRSP | Stock Option (Right to Buy) | D | 59,70 | 15 000 | 15 000 | |||||
| 2020-06-15 | 2020-06-11 | 4 | Bolzon Bradley J PhD | CRSP | Stock Option (Right to Buy) | I | 59,70 | 15 000 | 15 000 | |||||
| 2020-06-03 | 2020-06-02 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 66,2600 | −779 | −52 | 170 747 | ||||
| 2020-06-03 | 2020-06-01 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 1,81 | −17 275 | 162 783 | |||||
| 2020-06-03 | 2020-06-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 65,2600 | −5 575 | −364 | 171 526 | ||||
| 2020-06-03 | 2020-06-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 64,6100 | −9 300 | −601 | 177 101 | ||||
| 2020-06-03 | 2020-06-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 63,5700 | −2 400 | −153 | 186 401 | ||||
| 2020-06-03 | 2020-06-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 17 275 | 31 | 188 801 | ||||
| 2020-05-27 | 2020-05-26 | 4 | Ho Tony W | CRSP | Common Shares | D | 70,1400 | −6 100 | −428 | 40 905 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Ho Tony W | CRSP | Common Shares | D | 70,0500 | −600 | −42 | 47 005 | ||||
| 2020-05-27 | 2020-05-26 | 4 | Novak Rodger | CRSP | Common Shares | D | 70,2700 | −36 616 | −2 573 | 748 007 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Novak Rodger | CRSP | Common Shares | D | 70,0100 | −13 384 | −937 | 784 623 | ||||
| 2020-05-21 | 2020-05-19 | 4 | Novak Rodger | CRSP | Common Shares | D | 65,0000 | −50 000 | −3 250 | 798 007 | ||||
| 2020-05-21 | 2020-05-20 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 1,81 | −10 693 | 180 058 | |||||
| 2020-05-21 | 2020-05-20 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 65,2800 | −10 693 | −698 | 171 526 | ||||
| 2020-05-21 | 2020-05-20 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 10 693 | 19 | 182 219 | ||||
| 2020-05-21 | 2020-05-19 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 1,81 | −4 307 | 190 751 | |||||
| 2020-05-21 | 2020-05-19 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 65,1600 | −4 307 | −281 | 171 526 | ||||
| 2020-05-21 | 2020-05-19 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 4 307 | 8 | 175 833 | ||||
| 2020-05-13 | 2020-05-11 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 5,86 | −25 000 | 38 666 | |||||
| 2020-05-13 | 2020-05-11 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 61,0700 | −682 | −42 | 20 000 | ||||
| 2020-05-13 | 2020-05-11 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 60,3800 | −24 318 | −1 468 | 20 682 | ||||
| 2020-05-13 | 2020-05-11 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 5,8600 | 25 000 | 146 | 45 000 | ||||
| 2020-03-12 | 2020-03-10 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Restricted Stock Units | D | 8 500 | 8 500 | ||||||
| 2020-03-12 | 2020-03-10 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Stock Option (Right to Buy) | D | 44,67 | 35 000 | 35 000 | |||||
| 2020-03-12 | 2020-03-10 | 4 | KASINGER JAMES R. | CRSP | Restricted Stock Units | D | 8 500 | 8 500 | ||||||
| 2020-03-12 | 2020-03-10 | 4 | KASINGER JAMES R. | CRSP | Stock Option (Right to Buy) | D | 44,67 | 35 000 | 35 000 | |||||
| 2020-03-12 | 2020-03-10 | 4 | Ho Tony W | CRSP | Restricted Stock Units | D | 13 750 | 13 750 | ||||||
| 2020-03-12 | 2020-03-10 | 4 | Ho Tony W | CRSP | Stock Option (Right to Buy) | D | 44,67 | 55 000 | 55 000 | |||||
| 2020-03-12 | 2020-03-10 | 4 | Kulkarni Samarth | CRSP | Restricted Stock Units | D | 35 500 | 35 500 | ||||||
| 2020-03-12 | 2020-03-10 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 44,67 | 142 000 | 142 000 | |||||
| 2020-03-12 | 2020-03-10 | 4 | Klein Lawrence Otto | CRSP | Restricted Stock Units | D | 13 750 | 13 750 | ||||||
| 2020-03-12 | 2020-03-10 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 44,67 | 55 000 | 55 000 | |||||
| 2020-03-09 | 2020-03-06 | 4 | Ho Tony W | CRSP | Common Shares | D | 52,6400 | −1 563 | −82 | 47 605 | ||||
| 2020-03-09 | 2020-03-05 | 4 | Ho Tony W | CRSP | Common Shares | D | 3 333 | 49 168 | ||||||
| 2020-03-04 | 2020-03-02 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 52,7400 | −794 | −42 | 171 526 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 1,81 | −8 000 | 195 058 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 8 000 | 14 | 172 320 | ||||
| 2019-12-05 | 2019-12-03 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Restricted Stock Units | D | 20 000 | 20 000 | ||||||
| 2019-12-05 | 2019-12-03 | 4 | Kulkarni Samarth | CRSP | Restricted Stock Units | D | 120 000 | 120 000 | ||||||
| 2019-12-05 | 2019-12-03 | 4 | Klein Lawrence Otto | CRSP | Restricted Stock Units | D | 40 000 | 40 000 | ||||||
| 2019-12-05 | 2019-12-03 | 4 | KASINGER JAMES R. | CRSP | Restricted Stock Units | D | 20 000 | 20 000 | ||||||
| 2019-12-05 | 2019-12-03 | 4 | Ho Tony W | CRSP | Restricted Stock Units | D | 40 000 | 40 000 | ||||||
| 2019-12-02 | 2019-12-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 71,6500 | −741 | −53 | 164 320 | ||||
| 2019-11-21 | 2019-11-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 67,4140 | −28 255 | −1 905 | 596 741 | ||||
| 2019-11-21 | 2019-11-19 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 67,4140 | −13 745 | −927 | 0 | ||||
| 2019-11-21 | 2019-11-19 | 4 | CAGNONI PABLO J | CRSP | Stock Option (Right to Buy) | D | 5,59 | −7 500 | 63 833 | |||||
| 2019-11-21 | 2019-11-19 | 4 | CAGNONI PABLO J | CRSP | Common Shares | D | 62,0000 | −7 500 | −465 | 0 | ||||
| 2019-11-21 | 2019-11-19 | 4 | CAGNONI PABLO J | CRSP | Common Shares | D | 5,5900 | 7 500 | 42 | 7 500 | ||||
| 2019-11-21 | 2019-11-19 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,43 | −33 618 | 236 382 | |||||
| 2019-11-21 | 2019-11-19 | 4 | Novak Rodger | CRSP | Common Shares | D | 70,0000 | −33 618 | −2 353 | 0 | ||||
| 2019-11-21 | 2019-11-19 | 4 | Novak Rodger | CRSP | Common Shares | D | 14,4300 | 33 618 | 485 | 33 618 | ||||
| 2019-11-13 | 2019-11-12 | 4 | CAGNONI PABLO J | CRSP | Stock Option (Right to Buy) | D | 5,59 | −7 500 | 71 333 | |||||
| 2019-11-13 | 2019-11-12 | 4 | CAGNONI PABLO J | CRSP | Common Shares | D | 55,0000 | −7 500 | −412 | 0 | ||||
| 2019-11-13 | 2019-11-12 | 4 | CAGNONI PABLO J | CRSP | Common Shares | D | 5,5900 | 7 500 | 42 | 7 500 | ||||
| 2019-11-01 | 2019-10-30 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 51,8893 | −21 000 | −1 090 | 13 745 | ||||
| 2019-11-01 | 2019-10-30 | 4 | CAGNONI PABLO J | CRSP | Stock Option (Right to Buy) | D | 5,59 | −7 500 | 78 833 | |||||
| 2019-11-01 | 2019-10-30 | 4 | CAGNONI PABLO J | CRSP | Common Shares | D | 52,0000 | −7 500 | −390 | 0 | ||||
| 2019-11-01 | 2019-10-30 | 4 | CAGNONI PABLO J | CRSP | Common Shares | D | 5,5900 | 7 500 | 42 | 7 500 | ||||
| 2019-09-12 | 2019-09-10 | 4 | Klein Lawrence Otto | CRSP | Restricted Stock Units | D | 10 000 | 30 000 | ||||||
| 2019-09-12 | 2019-09-10 | 4 | KASINGER JAMES R. | CRSP | Restricted Stock Units | D | 10 000 | 10 000 | ||||||
| 2019-09-03 | 2019-09-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 46,2100 | −740 | −34 | 165 061 | ||||
| 2019-08-05 | 2019-08-02 | 4 | Ho Tony W | CRSP | Common Shares | D | 52,5600 | −14 534 | −764 | 45 835 | ||||
| 2019-08-05 | 2019-08-01 | 4 | Ho Tony W | CRSP | Restricted Stock Units | D | −37 500 | 0 | ||||||
| 2019-08-05 | 2019-08-01 | 4 | Ho Tony W | CRSP | Common Shares | D | 37 500 | 60 369 | ||||||
| 2019-07-12 | 2019-07-10 | 4 | Novak Rodger | CRSP | Common Shares | D | 50,0013 | −50 000 | −2 500 | 848 007 | ||||
| 2019-07-12 | 2019-07-11 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 5,86 | −8 421 | 63 666 | |||||
| 2019-07-12 | 2019-07-11 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 50,0144 | −8 421 | −421 | 20 000 | ||||
| 2019-07-12 | 2019-07-11 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 5,8600 | 8 421 | 49 | 28 421 | ||||
| 2019-07-12 | 2019-07-10 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 5,86 | −11 579 | 72 087 | |||||
| 2019-07-12 | 2019-07-10 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 50,0200 | −11 579 | −579 | 20 000 | ||||
| 2019-07-12 | 2019-07-10 | 4 | Klein Lawrence Otto | CRSP | Common Shares | D | 5,8600 | 11 579 | 68 | 31 579 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 1,81 | −20 000 | 203 058 | |||||
| 2019-06-19 | 2019-06-17 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 46,0000 | −20 000 | −920 | 165 801 | ||||
| 2019-06-19 | 2019-06-17 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 20 000 | 36 | 185 801 | ||||
| 2019-06-13 | 2019-06-11 | 4 | High Katherine A | CRSP | Stock Option (Right to Buy) | D | 43,52 | 30 000 | 30 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | George Simeon | CRSP | Stock Option (Right to Buy) | D | 43,52 | 15 000 | 15 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | CAGNONI PABLO J | CRSP | Stock Option (Right to Buy) | D | 43,52 | 15 000 | 15 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Greene John | CRSP | Stock Option (Right to Buy) | D | 43,52 | 30 000 | 30 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Bolzon Bradley J PhD | CRSP | Stock Option (Right to Buy) | I | 43,52 | 15 000 | 15 000 | |||||
| 2019-06-13 | 2019-06-11 | 4 | Behbahani Ali | CRSP | Stock Option (Right to Buy) | D | 43,52 | 15 000 | 15 000 | |||||
| 2019-06-12 | 2019-06-10 | 4 | Novak Rodger | CRSP | Common Shares | D | 45,0000 | −50 000 | −2 250 | 898 007 | ||||
| 2019-06-04 | 2019-06-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 35,5700 | −741 | −26 | 165 801 | ||||
| 2019-05-01 | 2019-04-29 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 1,81 | −20 000 | 223 058 | |||||
| 2019-05-01 | 2019-04-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 42,0300 | −20 000 | −841 | 166 542 | ||||
| 2019-05-01 | 2019-04-29 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 20 000 | 36 | 186 542 | ||||
| 2019-03-07 | 2019-03-05 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 40,87 | 250 000 | 250 000 | |||||
| 2019-03-07 | 2019-03-05 | 4 | Ho Tony W | CRSP | Stock Option (Right to Buy) | D | 40,87 | 75 000 | 75 000 | |||||
| 2019-03-07 | 2019-03-05 | 4 | Ho Tony W | CRSP | Restricted Stock Units | D | 40,8700 | 10 000 | 409 | 32 869 | ||||
| 2019-03-07 | 2019-03-05 | 4 | KASINGER JAMES R. | CRSP | Stock Option (Right to Buy) | D | 40,87 | 65 000 | 65 000 | |||||
| 2019-03-07 | 2019-03-05 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Stock Option (Right to Buy) | D | 40,87 | 75 000 | 75 000 | |||||
| 2019-03-07 | 2019-03-05 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 40,87 | 45 000 | 45 000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 39,9700 | −748 | −30 | 166 542 | ||||
| 2019-03-05 | 2019-03-04 | 4 | Novak Rodger | CRSP | Common Shares | D | 42,0300 | −3 500 | −147 | 948 007 | ||||
| 2019-03-05 | 2019-03-04 | 4 | Novak Rodger | CRSP | Common Shares | D | 41,2869 | −8 912 | −368 | 951 507 | ||||
| 2019-03-05 | 2019-03-04 | 4 | Novak Rodger | CRSP | Common Shares | D | 40,2431 | −64 115 | −2 580 | 960 419 | ||||
| 2019-03-05 | 2019-03-01 | 4 | Novak Rodger | CRSP | Common Shares | D | 40,0088 | −8 693 | −348 | 1 024 534 | ||||
| 2019-02-27 | 2019-02-25 | 4 | Novak Rodger | CRSP | Common Shares | D | 40,0022 | −14 780 | −591 | 1 033 227 | ||||
| 2019-01-18 | 2018-12-18 | 4/A | EMSTER KURT VON | CRSP | Common Shares | I | 29,7047 | −62 925 | −1 869 | 1 171 268 | ||||
| 2019-01-10 | 2019-01-09 | 4 | Novak Rodger | CRSP | Common Shares | D | 35,0100 | −82 690 | −2 895 | 1 048 007 | ||||
| 2019-01-10 | 2019-01-08 | 4 | Novak Rodger | CRSP | Common Shares | D | 35,0900 | −17 310 | −607 | 1 130 697 | ||||
| 2019-01-03 | 2019-01-02 | 4 | Klein Lawrence Otto | CRSP | Stock Option (Right to Buy) | D | 29,87 | 20 000 | 20 000 | |||||
| 2019-01-03 | 2019-01-02 | 4 | Klein Lawrence Otto | CRSP | Restricted Stock Units | D | 29,8700 | 20 000 | 597 | 20 000 | ||||
| 2018-12-28 | 2018-12-27 | 4 | Vertex Pharmaceuticals (Europe) Ltd | CRSP | Common Shares | D | 24,9487 | 27 461 | 685 | 5 380 940 | ||||
| 2018-12-28 | 2018-12-26 | 4 | Vertex Pharmaceuticals (Europe) Ltd | CRSP | Common Shares | D | 24,8942 | 12 737 | 317 | 5 353 479 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Vertex Pharmaceuticals (Europe) Ltd | CRSP | Common Shares | D | 24,9687 | 53 655 | 1 340 | 5 340 742 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Vertex Pharmaceuticals (Europe) Ltd | CRSP | Common Shares | D | 23,1766 | 11 742 | 272 | 5 287 087 | ||||
| 2018-12-26 | 2018-12-24 | 4 | Vertex Pharmaceuticals (Europe) Ltd | CRSP | Common Shares | D | 22,9147 | 2 603 | 60 | 5 275 345 | ||||
| 2018-12-26 | 2018-12-21 | 4 | Vertex Pharmaceuticals (Europe) Ltd | CRSP | Common Shares | D | 22,5784 | 22 742 | 513 | 5 272 742 | ||||
| 2018-12-21 | 3 | VERTEX PHARMACEUTICALS INC / MA | CRSP | Common Shares | D | 10 500 000 | ||||||||
| 2018-12-21 | 3 | VERTEX PHARMACEUTICALS INC / MA | CRSP | Common Shares | D | 10 500 000 | ||||||||
| 2018-12-21 | 3 | VERTEX PHARMACEUTICALS INC / MA | CRSP | Common Shares | D | 10 500 000 | ||||||||
| 2018-12-21 | 3 | VERTEX PHARMACEUTICALS INC / MA | CRSP | Common Shares | D | 10 500 000 | ||||||||
| 2018-12-19 | 2018-12-18 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 29,7047 | −69 925 | −2 077 | 1 164 268 | ||||
| 2018-12-19 | 2018-12-17 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 33,1662 | −3 009 | −100 | 1 234 193 | ||||
| 2018-12-11 | 2018-12-07 | 4 | Kulkarni Samarth | CRSP | Stock Options (Right to Buy) | D | 1,81 | −21 500 | 243 058 | |||||
| 2018-12-11 | 2018-12-07 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 21 500 | 39 | 167 290 | ||||
| 2018-12-03 | 2018-12-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 38,3300 | −741 | −28 | 145 790 | ||||
| 2018-09-04 | 2018-09-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 56,6700 | −741 | −42 | 146 531 | ||||
| 2018-08-03 | 2018-08-02 | 4 | Ho Tony W | CRSP | Common Shares | D | 48,4300 | −14 631 | −709 | 22 869 | ||||
| 2018-08-03 | 2018-08-01 | 4 | Ho Tony W | CRSP | Restricted Stock Units | D | −37 500 | 37 500 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Ho Tony W | CRSP | Common Shares | D | 37 500 | 37 500 | ||||||
| 2018-07-05 | 2018-07-05 | 4 | CAGNONI PABLO J | CRSP | Stock Option (Right to Buy) | D | 5,59 | 1 684 | 86 333 | |||||
| 2018-07-05 | 2018-07-05 | 4 | CAGNONI PABLO J | CRSP | Common Shares | D | 62,0000 | −1 684 | −104 | 0 | ||||
| 2018-07-05 | 2018-07-05 | 4 | CAGNONI PABLO J | CRSP | Common Shares | D | 5,5900 | 1 684 | 9 | 1 684 | ||||
| 2018-07-05 | 2018-07-03 | 4 | CAGNONI PABLO J | CRSP | Stock Option (Right to Buy) | D | 5,59 | 5 816 | 88 017 | |||||
| 2018-07-05 | 2018-07-03 | 4 | CAGNONI PABLO J | CRSP | Common Shares | D | 62,0000 | −5 816 | −361 | 0 | ||||
| 2018-07-05 | 2018-07-03 | 4 | CAGNONI PABLO J | CRSP | Common Shares | D | 5,5900 | 5 816 | 33 | 5 816 | ||||
| 2018-06-19 | 2018-06-15 | 4 | George Simeon | CRSP | Stock Option (Right to Buy) | D | 59,31 | 15 000 | 15 000 | |||||
| 2018-06-18 | 2018-06-15 | 4 | EMSTER KURT VON | CRSP | Stock Option (Right to Buy) | D | 59,31 | 15 000 | 15 000 | |||||
| 2018-06-15 | 2018-06-15 | 4 | Woiwode Thomas See Footnotes | CRSP | Stock Option (Right to Buy) | I | 59,31 | 30 000 | 30 000 | |||||
| 2018-06-15 | 2018-06-15 | 4 | Bolzon Bradley J PhD See Footnotes | CRSP | Stock Option (Right to Buy) | I | 59,31 | 30 000 | 30 000 | |||||
| 2018-06-15 | 2018-06-15 | 4 | KASINGER JAMES R. | CRSP | Stock Option (Right to Buy) | D | 59,31 | 32 000 | 32 000 | |||||
| 2018-06-15 | 2018-06-15 | 4 | Behbahani Ali | CRSP | Stock Option (Right to Buy) | D | 59,31 | 15 000 | 15 000 | |||||
| 2018-06-15 | 2018-06-15 | 4 | CAGNONI PABLO J | CRSP | Stock Option (Right to Buy) | D | 59,31 | 15 000 | 15 000 | |||||
| 2018-06-15 | 2018-06-15 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 59,31 | 109 000 | 109 000 | |||||
| 2018-06-15 | 2018-06-15 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Stock Option (Right to Buy) | D | 59,31 | 20 760 | 20 760 | |||||
| 2018-06-15 | 2018-06-15 | 4 | Ho Tony W | CRSP | Stock Option (Right to Buy) | D | 59,31 | 43 000 | 43 000 | |||||
| 2018-06-07 | 2018-06-05 | 4 | EMSTER KURT VON By The Konrad Hans von Emster III and Elizabeth F. von Emster Revocable Trust dated January 18, 2005 | CRSP | Warrant (right to buy) | I | 5,75 | −2 000 | 0 | |||||
| 2018-06-07 | 2018-06-05 | 4 | EMSTER KURT VON By the Konrad Hans von Emster III and Elizabeth F. von Emster Revocable Trust dated January 18, 2005 | CRSP | Common Stock | I | 12,5100 | −920 | −12 | 18 316 | ||||
| 2018-06-07 | 2018-06-05 | 4 | EMSTER KURT VON By the Konrad Hans von Emster III and Elizabeth F. von Emster Revocable Trust dated January 18, 2005 | CRSP | Common Stock | I | 5,7500 | −2 000 | −12 | 19 236 | ||||
| 2018-06-05 | 2018-06-04 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 67,1300 | −741 | −50 | 147 819 | ||||
| 2018-06-05 | 2018-06-01 | 4 | Kulkarni Samarth | CRSP | Employee Stock Option (right to buy) | D | 1,81 | −15 000 | 264 558 | |||||
| 2018-06-05 | 2018-06-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 70,2800 | −10 400 | −731 | 148 560 | ||||
| 2018-06-05 | 2018-06-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 67,2800 | −4 600 | −309 | 158 960 | ||||
| 2018-06-05 | 2018-06-01 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 15 000 | 27 | 163 560 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,00 | −39 760 | 160 240 | |||||
| 2018-05-21 | 2018-05-17 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 1,81 | −35 240 | 5 586 | |||||
| 2018-05-21 | 2018-05-17 | 4 | Novak Rodger | CRSP | Common Shares | D | 60,0000 | −75 000 | −4 500 | 1 148 007 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Novak Rodger | CRSP | Common Shares | D | 14,0000 | 39 760 | 557 | 1 223 007 | ||||
| 2018-05-21 | 2018-05-17 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 35 240 | 64 | 1 183 247 | ||||
| 2018-05-17 | 2018-05-15 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 58,7300 | −1 000 | −59 | 640 014 | ||||
| 2018-05-17 | 2018-05-15 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 57,9700 | −43 000 | −2 493 | 641 014 | ||||
| 2018-05-17 | 2018-05-15 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 58,7300 | −1 000 | −59 | 640 014 | ||||
| 2018-05-17 | 2018-05-15 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 57,9700 | −43 000 | −2 493 | 641 014 | ||||
| 2018-05-15 | 2018-05-14 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 52,1955 | −8 900 | −465 | 1 237 202 | ||||
| 2018-05-15 | 2018-05-14 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 52,9339 | −20 881 | −1 105 | 1 246 102 | ||||
| 2018-05-15 | 2018-05-14 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 53,8613 | −53 927 | −2 905 | 1 266 983 | ||||
| 2018-05-15 | 2018-05-14 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 54,9899 | −126 901 | −6 978 | 1 320 910 | ||||
| 2018-05-15 | 2018-05-14 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 55,7219 | −73 144 | −4 076 | 1 447 811 | ||||
| 2018-05-15 | 2018-05-14 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 56,8972 | −116 247 | −6 614 | 1 520 955 | ||||
| 2018-05-15 | 2018-05-11 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 51,7264 | −8 633 | −447 | 1 637 202 | ||||
| 2018-05-15 | 2018-05-11 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 52,4561 | −127 890 | −6 709 | 1 645 835 | ||||
| 2018-05-15 | 2018-05-11 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 53,3565 | −113 477 | −6 055 | 1 773 725 | ||||
| 2018-05-15 | 2018-05-14 | 4 | Behbahani Ali | CRSP | Common Stock | D | 199 | 199 | ||||||
| 2018-05-09 | 2018-05-08 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 51,3800 | −2 900 | −149 | 34 745 | ||||
| 2018-05-09 | 2018-05-08 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 50,1600 | −6 341 | −318 | 37 645 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 51,2600 | −582 | −30 | 90 730 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 51,2600 | −249 | −13 | 38 772 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 51,2600 | −225 | −12 | 34 977 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 51,2600 | −7 645 | −392 | 1 192 139 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,3100 | −7 424 | −374 | 91 312 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,3100 | −3 172 | −160 | 39 021 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,3100 | −2 862 | −144 | 35 202 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,3100 | −97 550 | −4 908 | 1 199 784 | ||||
| 2018-05-09 | 2018-05-08 | 4 | Woiwode Thomas | CRSP | Common Shares | D | 51,4500 | −1 653 | −85 | 5 629 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 51,2600 | −582 | −30 | 90 730 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 51,2600 | −249 | −13 | 38 772 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 51,2600 | −225 | −12 | 34 977 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 51,2600 | −7 645 | −392 | 1 192 139 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,3100 | −7 424 | −374 | 91 312 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,3100 | −3 172 | −160 | 39 021 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,3100 | −2 862 | −144 | 35 202 | ||||
| 2018-05-09 | 2018-05-07 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,3100 | −97 550 | −4 908 | 1 199 784 | ||||
| 2018-05-02 | 2018-04-30 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,2900 | −2 044 | −103 | 98 736 | ||||
| 2018-05-02 | 2018-04-30 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,2600 | −874 | −44 | 42 193 | ||||
| 2018-05-02 | 2018-04-30 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,2900 | −788 | −40 | 38 064 | ||||
| 2018-05-02 | 2018-04-30 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,2900 | −26 860 | −1 351 | 1 297 334 | ||||
| 2018-05-02 | 2018-04-30 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,2900 | −2 044 | −103 | 98 736 | ||||
| 2018-05-02 | 2018-04-30 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,2600 | −874 | −44 | 42 193 | ||||
| 2018-05-02 | 2018-04-30 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,2900 | −788 | −40 | 38 064 | ||||
| 2018-05-02 | 2018-04-30 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,2900 | −26 860 | −1 351 | 1 297 334 | ||||
| 2018-04-30 | 2018-04-27 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,0300 | −779 | −39 | 100 780 | ||||
| 2018-04-30 | 2018-04-27 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,0100 | −333 | −17 | 43 067 | ||||
| 2018-04-30 | 2018-04-27 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,0800 | −300 | −15 | 38 852 | ||||
| 2018-04-30 | 2018-04-27 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,0200 | −10 236 | −512 | 1 324 194 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,1100 | −14 086 | −706 | 101 559 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,1200 | −6 019 | −302 | 43 400 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,1200 | −5 430 | −272 | 39 152 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,1100 | −185 075 | −9 274 | 1 334 430 | ||||
| 2018-04-30 | 2018-04-27 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,0300 | −779 | −39 | 100 780 | ||||
| 2018-04-30 | 2018-04-27 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,0100 | −333 | −17 | 43 067 | ||||
| 2018-04-30 | 2018-04-27 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,0800 | −300 | −15 | 38 852 | ||||
| 2018-04-30 | 2018-04-27 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,0200 | −10 236 | −512 | 1 324 194 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,1100 | −14 086 | −706 | 101 559 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,1200 | −6 019 | −302 | 43 400 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,1200 | −5 430 | −272 | 39 152 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,1100 | −185 075 | −9 274 | 1 334 430 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Versant Venture Capital V, L.P. | CRSP | Common Shares | I | 51,0000 | −1 528 | −78 | 115 645 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Versant Venture Capital V, L.P. | CRSP | Common Shares | I | 51,0000 | −653 | −33 | 49 419 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Versant Venture Capital V, L.P. | CRSP | Common Shares | I | 50,6000 | −589 | −30 | 44 582 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Versant Venture Capital V, L.P. | CRSP | Common Shares | I | 51,0000 | −20 071 | −1 024 | 1 519 505 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 51,0000 | −1 528 | −78 | 115 645 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 51,0000 | −653 | −33 | 49 419 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,6000 | −589 | −30 | 44 582 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 51,0000 | −20 071 | −1 024 | 1 519 505 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 51,0000 | −1 528 | −78 | 115 645 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 51,0000 | −653 | −33 | 49 419 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,6000 | −589 | −30 | 44 582 | ||||
| 2018-04-26 | 2018-04-24 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 51,0000 | −20 071 | −1 024 | 1 519 505 | ||||
| 2018-04-24 | 2018-04-23 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,6600 | −6 821 | −346 | 117 173 | ||||
| 2018-04-24 | 2018-04-23 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 51,0000 | −2 915 | −149 | 50 072 | ||||
| 2018-04-24 | 2018-04-23 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 51,0000 | −2 630 | −134 | 45 171 | ||||
| 2018-04-24 | 2018-04-23 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 50,6600 | −89 628 | −4 541 | 1 539 576 | ||||
| 2018-04-24 | 2018-04-20 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 16 262 | 43 986 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −92 918 | 0 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 92 918 | 92 918 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −2 947 | 13 277 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | I | −497 053 | 2 238 979 | ||||||
| 2018-04-24 | 2018-04-23 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,6600 | −6 821 | −346 | 117 173 | ||||
| 2018-04-24 | 2018-04-23 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 51,0000 | −2 915 | −149 | 50 072 | ||||
| 2018-04-24 | 2018-04-23 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 51,0000 | −2 630 | −134 | 45 171 | ||||
| 2018-04-24 | 2018-04-23 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 50,6600 | −89 628 | −4 541 | 1 539 576 | ||||
| 2018-04-24 | 2018-04-20 | 4 | Woiwode Thomas | CRSP | Common Shares | D | 2 323 | 7 282 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Woiwode Thomas | CRSP | Common Shares | I | −92 918 | 0 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Woiwode Thomas | CRSP | Common Shares | I | 92 918 | 92 918 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Woiwode Thomas | CRSP | Common Shares | I | −2 947 | 13 277 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Woiwode Thomas | CRSP | Common Shares | I | −497 053 | 2 238 979 | ||||||
| 2018-04-24 | 2018-04-23 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Shares | I | 50,6600 | −6 821 | −346 | 117 173 | ||||
| 2018-04-24 | 2018-04-23 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Shares | I | 51,0000 | −2 915 | −149 | 50 072 | ||||
| 2018-04-24 | 2018-04-23 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Shares | I | 51,0000 | −2 630 | −134 | 45 171 | ||||
| 2018-04-24 | 2018-04-23 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Shares | I | 50,6600 | −89 628 | −4 541 | 1 539 576 | ||||
| 2018-04-24 | 2018-04-20 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Shares | I | −92 918 | 0 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Shares | I | 92 918 | 92 918 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Shares | I | −2 947 | 13 277 | ||||||
| 2018-04-24 | 2018-04-20 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Shares | I | −497 053 | 2 238 979 | ||||||
| 2018-04-18 | 2018-04-16 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 19,12 | −75 000 | 150 000 | |||||
| 2018-03-14 | 2017-12-01 | 4 | Kulkarni Samarth | CRSP | Stock option (right to buy) | D | 19,12 | −75 000 | 75 000 | |||||
| 2018-03-09 | 2018-03-07 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Stock Option (Right to Buy) | D | 51,49 | 25 000 | 25 000 | |||||
| 2018-03-09 | 2018-03-07 | 4 | KASINGER JAMES R. | CRSP | Stock Option (Right to Buy) | D | 51,49 | 40 000 | 40 000 | |||||
| 2018-03-09 | 2018-03-07 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 51,49 | 136 000 | 136 000 | |||||
| 2018-03-09 | 2018-03-07 | 4 | Ho Tony W | CRSP | Stock Option (Right to Buy) | D | 51,49 | 53 000 | 53 000 | |||||
| 2018-01-30 | 2018-01-05 | 4 | BAYER AKTIENGESELLSCHAFT By subsidiary | CRSP | Common Shares | I | 22,7500 | 527 472 | 12 000 | 5 632 802 | ||||
| 2018-01-18 | 2018-01-16 | 4 | Dylan-Hyde Tyler | CRSP | Stock Option (Right to Buy) | D | 12,57 | −19 890 | 5 237 | |||||
| 2018-01-18 | 2018-01-16 | 4 | Dylan-Hyde Tyler | CRSP | Stock Option (Right to Buy) | D | 12,57 | −1 110 | 36 663 | |||||
| 2018-01-18 | 2018-01-16 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 28,1000 | −19 890 | −559 | 25 204 | ||||
| 2018-01-18 | 2018-01-16 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 12,5700 | 19 890 | 250 | 45 094 | ||||
| 2018-01-18 | 2018-01-16 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 28,2400 | −1 110 | −31 | 25 204 | ||||
| 2018-01-18 | 2018-01-16 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 12,5700 | 1 110 | 14 | 26 314 | ||||
| 2018-01-18 | 2018-01-16 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 28,0000 | −45 000 | −1 260 | 25 204 | ||||
| 2018-01-11 | 2018-01-05 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 22,7500 | 65 934 | 1 500 | 1 887 202 | ||||
| 2018-01-09 | 2018-01-05 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 26,9600 | −92 337 | −2 489 | 1 821 268 | ||||
| 2018-01-04 | 2018-01-02 | 4 | Dylan-Hyde Tyler | CRSP | Stock Option (Right to Buy) | D | 12,57 | −1 510 | 25 157 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Dylan-Hyde Tyler | CRSP | Stock Option (Right to Buy) | D | 12,57 | −6 490 | 37 773 | |||||
| 2018-01-04 | 2018-01-02 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 25,7500 | −8 000 | −206 | 70 204 | ||||
| 2018-01-04 | 2018-01-02 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 12,5700 | 8 000 | 101 | 78 204 | ||||
| 2018-01-04 | 2018-01-02 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 20,5500 | −30 000 | −616 | 70 204 | ||||
| 2018-01-04 | 2018-01-02 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 26,7554 | −37 754 | −1 010 | 1 913 605 | ||||
| 2018-01-02 | 2017-12-29 | 4 | Dylan-Hyde Tyler | CRSP | Stock Option (Right to Buy) | D | 12,57 | −9 070 | 44 263 | |||||
| 2018-01-02 | 2017-12-29 | 4 | Dylan-Hyde Tyler | CRSP | Stock Option (Right to Buy) | D | 14,43 | −6 230 | 58 070 | |||||
| 2018-01-02 | 2017-12-29 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 22,6800 | −15 000 | −340 | 100 204 | ||||
| 2018-01-02 | 2017-12-29 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 23,7600 | −8 000 | −190 | 115 204 | ||||
| 2018-01-02 | 2017-12-29 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 21,7500 | −1 070 | −23 | 123 204 | ||||
| 2018-01-02 | 2017-12-29 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 12,5700 | 9 070 | 114 | 124 274 | ||||
| 2018-01-02 | 2017-12-29 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 21,7500 | −6 230 | −136 | 115 204 | ||||
| 2018-01-02 | 2017-12-29 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 14,4300 | 6 230 | 90 | 121 434 | ||||
| 2018-01-02 | 2017-12-28 | 4 | Dylan-Hyde Tyler | CRSP | Stock Option (Right to Buy) | D | 14,43 | −700 | 64 300 | |||||
| 2018-01-02 | 2017-12-28 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 21,7500 | −700 | −15 | 115 204 | ||||
| 2018-01-02 | 2017-12-28 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 14,4300 | 700 | 10 | 115 904 | ||||
| 2017-12-27 | 2017-12-22 | 4 | Woiwode Thomas | CRSP | Common Shares | D | 20,2911 | −3 059 | −62 | 4 959 | ||||
| 2017-12-27 | 2017-12-22 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 20,3043 | −26 016 | −528 | 27 724 | ||||
| 2017-12-27 | 2017-12-22 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 20,5500 | −15 000 | −308 | 115 204 | ||||
| 2017-12-26 | 2017-12-21 | 4 | Kulkarni Samarth | CRSP | Employee Stock Option (right to buy) | D | 1,81 | −15 000 | 279 558 | |||||
| 2017-12-26 | 2017-12-21 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 15 000 | 27 | 148 560 | ||||
| 2017-12-19 | 2017-12-15 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 18,8997 | −15 000 | −283 | 130 204 | ||||
| 2017-12-07 | 2018-11-21 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 19,2500 | −80 000 | −1 540 | 4 173 019 | ||||
| 2017-12-07 | 2017-12-04 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 19,4700 | −30 485 | −594 | 3 722 534 | ||||
| 2017-12-07 | 2017-12-01 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 19,1000 | −87 991 | −1 681 | 3 753 019 | ||||
| 2017-12-07 | 2017-11-30 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 19,0400 | −12 666 | −241 | 3 841 010 | ||||
| 2017-12-07 | 2017-11-29 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 19,2500 | −4 263 | −82 | 3 853 676 | ||||
| 2017-12-07 | 2017-11-28 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 19,2200 | −5 080 | −98 | 3 857 939 | ||||
| 2017-12-07 | 2017-11-27 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 19,7500 | −27 990 | −553 | 3 863 019 | ||||
| 2017-12-07 | 2017-11-24 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 20,0000 | −26 010 | −520 | 3 891 009 | ||||
| 2017-12-07 | 2017-11-22 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 19,7600 | −256 000 | −5 059 | 3 917 019 | ||||
| 2017-12-07 | 2017-11-20 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 19,0200 | −158 718 | −3 019 | 4 253 019 | ||||
| 2017-12-07 | 2017-11-17 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 18,4400 | −51 282 | −946 | 4 411 737 | ||||
| 2017-12-07 | 2017-11-16 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 18,3900 | −105 000 | −1 931 | 4 463 019 | ||||
| 2017-12-07 | 2017-11-15 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 17,6700 | −15 000 | −265 | 4 568 019 | ||||
| 2017-12-07 | 2017-11-14 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 17,1900 | −14 907 | −256 | 4 583 019 | ||||
| 2017-12-07 | 2017-11-13 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 17,7600 | −65 093 | −1 156 | 4 597 926 | ||||
| 2017-12-07 | 2017-11-10 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 17,2800 | −10 000 | −173 | 4 663 019 | ||||
| 2017-12-07 | 2017-11-09 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 17,0800 | −20 000 | −342 | 4 673 019 | ||||
| 2017-12-07 | 2017-11-08 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 18,0600 | −16 875 | −305 | 4 693 019 | ||||
| 2017-12-07 | 2017-11-07 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 18,5400 | −23 000 | −426 | 4 709 894 | ||||
| 2017-12-07 | 2017-11-06 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 18,8900 | −79 327 | −1 498 | 4 732 894 | ||||
| 2017-12-07 | 2017-11-03 | 4 | CELGENE CORP /DE/ See explanation of responses | CRSP | Common Stock | I | 19,1000 | −22 759 | −435 | 4 812 221 | ||||
| 2017-12-05 | 2017-12-01 | 4 | Kulkarni Samarth | CRSP | Stock Option (Right to Buy) | D | 19,12 | 260 000 | 260 000 | |||||
| 2017-12-05 | 2017-12-01 | 4 | Kulkarni Samarth | CRSP | Restricted Stock Units | D | 19,1200 | 26 667 | 510 | 133 560 | ||||
| 2017-11-28 | 2017-11-27 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 20,2400 | −200 | −4 | 53 740 | ||||
| 2017-11-28 | 2017-11-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 20,2060 | −1 507 | −30 | 53 940 | ||||
| 2017-11-28 | 2017-11-27 | 4 | Woiwode Thomas | CRSP | Common Shares | D | 20,2400 | −200 | −4 | 8 018 | ||||
| 2017-11-28 | 2017-11-24 | 4 | Woiwode Thomas | CRSP | Common Shares | D | 20,2105 | −1 700 | −34 | 8 218 | ||||
| 2017-11-14 | 2017-11-13 | 4 | TOMSICEK MICHAEL JOHN | CRSP | Stock Option (Right to Buy) | D | 17,75 | 180 000 | 180 000 | |||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | D | 55 447 | 55 447 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | −1 240 | 0 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 1 240 | 1 240 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | −17 283 | 0 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 17 283 | 17 283 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | −292 529 | 0 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 292 529 | 292 529 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | −26 491 | 52 987 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | −61 993 | 123 994 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | −23 899 | 47 801 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | −814 599 | 1 629 204 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | −8 110 | 16 224 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | −1 368 013 | 2 736 032 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | D | 9 918 | 9 918 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | −1 240 | 0 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 1 240 | 1 240 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | −17 283 | 0 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 17 283 | 17 283 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | −292 529 | 0 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 292 529 | 292 529 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | −26 491 | 52 987 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | −61 993 | 123 994 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | −23 899 | 47 801 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | −814 599 | 1 629 204 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | −8 110 | 16 224 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Woiwode Thomas | CRSP | Common Stock | I | −1 368 013 | 2 736 032 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | −1 240 | 0 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | 1 240 | 1 240 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | −17 283 | 0 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | 17 283 | 17 283 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | −292 529 | 0 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | 292 529 | 292 529 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | −26 491 | 52 987 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | −61 993 | 123 994 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | −23 899 | 47 801 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | −814 599 | 1 629 204 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | −8 110 | 16 224 | ||||||
| 2017-09-07 | 2017-09-05 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | −1 368 013 | 2 736 032 | ||||||
| 2017-09-05 | 2017-09-05 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −3 853 | 40 826 | |||||
| 2017-09-05 | 2017-09-05 | 4 | Novak Rodger | CRSP | Common Shares | D | 20,3271 | −3 853 | −78 | 1 148 007 | ||||
| 2017-09-05 | 2017-09-05 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 3 853 | 7 | 1 151 860 | ||||
| 2017-09-05 | 2017-08-31 | 4 | Novak Rodger | CRSP | Common Shares | D | 20,8711 | −14 617 | −305 | 1 148 007 | ||||
| 2017-08-30 | 2017-08-30 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −5 722 | 44 679 | |||||
| 2017-08-30 | 2017-08-30 | 4 | Novak Rodger | CRSP | Common Shares | D | 20,3079 | −58 103 | −1 180 | 1 162 624 | ||||
| 2017-08-30 | 2017-08-30 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 5 722 | 10 | 1 220 727 | ||||
| 2017-08-30 | 2017-08-28 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −17 692 | 50 401 | |||||
| 2017-08-30 | 2017-08-28 | 4 | Novak Rodger | CRSP | Common Shares | D | 20,0610 | −17 692 | −355 | 1 215 005 | ||||
| 2017-08-30 | 2017-08-28 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 17 692 | 32 | 1 232 697 | ||||
| 2017-08-30 | 2017-08-30 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 20,0000 | −4 000 | −80 | 106 893 | ||||
| 2017-08-30 | 2017-08-28 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 20,0899 | −23 154 | −465 | 110 893 | ||||
| 2017-08-30 | 2017-08-28 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 19,7900 | −88 011 | −1 742 | 1 951 359 | ||||
| 2017-08-28 | 2017-08-25 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 19,5200 | −14 913 | −291 | 2 039 370 | ||||
| 2017-08-28 | 2017-08-24 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 19,2300 | −7 868 | −151 | 2 054 283 | ||||
| 2017-08-24 | 2017-08-23 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 18,5300 | −7 035 | −130 | 2 062 151 | ||||
| 2017-08-24 | 2017-08-22 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 18,5300 | −10 954 | −203 | 2 069 186 | ||||
| 2017-08-22 | 2017-08-21 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 18,5100 | −1 250 | −23 | 2 080 140 | ||||
| 2017-08-22 | 2017-08-18 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 18,5300 | −1 900 | −35 | 2 081 390 | ||||
| 2017-08-18 | 2017-08-17 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 18,7400 | −13 593 | −255 | 2 083 290 | ||||
| 2017-08-18 | 2017-08-16 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 19,2700 | −20 548 | −396 | 2 096 883 | ||||
| 2017-08-16 | 2017-08-15 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 19,5300 | −25 586 | −500 | 2 117 431 | ||||
| 2017-08-16 | 2017-08-14 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 19,6400 | −29 983 | −589 | 2 143 017 | ||||
| 2017-08-09 | 2017-08-08 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 18,7100 | −19 850 | −371 | 2 190 872 | ||||
| 2017-08-09 | 2017-08-07 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 18,5300 | −15 623 | −289 | 2 210 722 | ||||
| 2017-08-08 | 2017-08-08 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 18,5998 | −1 313 | −24 | 153 204 | ||||
| 2017-08-08 | 2017-08-07 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 18,5624 | −13 210 | −245 | 154 517 | ||||
| 2017-08-08 | 2017-08-04 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 18,5500 | −477 | −9 | 167 727 | ||||
| 2017-08-07 | 2017-08-04 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 18,5000 | −3 068 | −57 | 2 226 345 | ||||
| 2017-08-07 | 2017-08-03 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 17,7700 | −47 409 | −842 | 2 229 413 | ||||
| 2017-08-02 | 2017-08-01 | 4 | Ho Tony W | CRSP | Stock Options (Right to Buy) | D | 16,90 | 260 000 | 260 000 | |||||
| 2017-08-02 | 2017-08-01 | 4 | Ho Tony W | CRSP | Restricted Stock Units | D | 75 000 | 75 000 | ||||||
| 2017-08-02 | 2017-08-01 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 17,5000 | −264 | −5 | 2 276 822 | ||||
| 2017-08-02 | 2017-07-31 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 17,5060 | −5 248 | −92 | 2 277 086 | ||||
| 2017-08-01 | 3 | Ho Tony W | CRSP | No securities are beneficially owned | D | 0 | ||||||||
| 2017-07-31 | 2017-07-28 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 17,6500 | −400 | −7 | 2 282 334 | ||||
| 2017-07-31 | 2017-07-27 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 17,6250 | −40 912 | −721 | 2 282 734 | ||||
| 2017-07-27 | 2017-07-26 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 17,6300 | −23 744 | −419 | 2 323 646 | ||||
| 2017-07-27 | 2017-07-25 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 17,5200 | −9 186 | −161 | 2 347 390 | ||||
| 2017-07-17 | 2017-07-14 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 16,8200 | −36 230 | −609 | 2 356 576 | ||||
| 2017-07-17 | 2017-07-13 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 16,8700 | −33 629 | −567 | 2 392 806 | ||||
| 2017-07-13 | 2017-07-12 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 16,6000 | −17 872 | −297 | 2 408 563 | ||||
| 2017-07-13 | 2017-07-11 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 16,5200 | −14 120 | −233 | 2 426 435 | ||||
| 2017-07-07 | 2017-07-05 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 16,2600 | −4 254 | −69 | 2 440 555 | ||||
| 2017-06-30 | 2017-06-29 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 16,5200 | −11 610 | −192 | 2 444 809 | ||||
| 2017-06-30 | 2017-06-28 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 17,0400 | −31 592 | −538 | 2 456 419 | ||||
| 2017-06-28 | 2017-06-27 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 17,4300 | −33 434 | −583 | 2 488 011 | ||||
| 2017-06-28 | 2017-06-26 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 16,8300 | −48 001 | −808 | 2 521 445 | ||||
| 2017-06-26 | 2017-06-23 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 16,2300 | −30 841 | −501 | 2 569 446 | ||||
| 2017-06-26 | 2017-06-22 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 16,2100 | −1 527 | −25 | 2 600 287 | ||||
| 2017-06-23 | 2017-06-22 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −10 825 | 68 093 | |||||
| 2017-06-23 | 2017-06-22 | 4 | Novak Rodger | CRSP | Common Shares | D | 15,3707 | −10 825 | −166 | 1 215 005 | ||||
| 2017-06-23 | 2017-06-22 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 10 825 | 20 | 1 225 830 | ||||
| 2017-06-21 | 2017-06-21 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −11 578 | 78 918 | |||||
| 2017-06-21 | 2017-06-21 | 4 | Novak Rodger | CRSP | Common Shares | D | 15,0152 | −11 578 | −174 | 1 215 005 | ||||
| 2017-06-21 | 2017-06-21 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 11 578 | 21 | 1 266 583 | ||||
| 2017-06-21 | 2017-06-20 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −3 252 | 90 496 | |||||
| 2017-06-21 | 2017-06-20 | 4 | Novak Rodger | CRSP | Common Shares | D | 15,0015 | −3 252 | −49 | 1 215 005 | ||||
| 2017-06-21 | 2017-06-20 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 3 252 | 6 | 1 218 257 | ||||
| 2017-06-21 | 2017-06-19 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −15 392 | 93 748 | |||||
| 2017-06-21 | 2017-06-19 | 4 | Novak Rodger | CRSP | Common Shares | D | 15,0000 | −15 392 | −231 | 1 215 005 | ||||
| 2017-06-21 | 2017-06-19 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 15 392 | 28 | 1 230 397 | ||||
| 2017-06-19 | 2017-06-15 | 4 | Subramanian Kala | CRSP | Stock Options (Right to Buy) | D | 14,43 | 85 000 | 85 000 | |||||
| 2017-06-19 | 2017-06-15 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 14,43 | 270 000 | 270 000 | |||||
| 2017-06-19 | 2017-06-15 | 4 | Dylan-Hyde Tyler | CRSP | Stock Option (Right to Buy) | D | 14,43 | 65 000 | 65 000 | |||||
| 2017-06-12 | 2017-06-09 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −1 100 | 109 140 | |||||
| 2017-06-12 | 2017-06-09 | 4 | Novak Rodger | CRSP | Common Shares | D | 15,0755 | −1 100 | −17 | 1 215 005 | ||||
| 2017-06-12 | 2017-06-09 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 1 100 | 2 | 1 216 105 | ||||
| 2017-06-12 | 2017-06-08 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −4 203 | 110 240 | |||||
| 2017-06-12 | 2017-06-08 | 4 | Novak Rodger | CRSP | Common Shares | D | 15,0000 | −4 203 | −63 | 1 215 005 | ||||
| 2017-06-12 | 2017-06-08 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 4 203 | 8 | 1 219 208 | ||||
| 2017-06-02 | 2017-05-31 | 4 | George Simeon | CRSP | Stock Option (Right to Buy) | D | 13,62 | 15 000 | 15 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | KASINGER JAMES R. | CRSP | Stock Options (Right to Buy) | D | 13,62 | 123 000 | 123 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Bolzon Bradley J PhD | CRSP | Stock Option (Right to Buy) | I | 13,62 | 30 000 | 30 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Woiwode Thomas | CRSP | Stock Option (Right to Buy) | I | 13,62 | 30 000 | 30 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | CAGNONI PABLO J | CRSP | Stock Option (Right to Buy) | D | 13,62 | 15 000 | 15 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | EMSTER KURT VON | CRSP | Stock Option (Right to Buy) | D | 13,62 | 15 000 | 15 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | Behbahani Ali | CRSP | Stock Option (Right to Buy) | D | 13,62 | 15 000 | 15 000 | |||||
| 2017-06-02 | 2017-05-31 | 4 | COLES N ANTHONY | CRSP | Stock Option (Right to Buy) | D | 13,62 | 15 000 | 15 000 | |||||
| 2017-06-01 | 3 | KASINGER JAMES R. | CRSP | Common Shares | D | 0 | ||||||||
| 2017-06-01 | 2017-05-30 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −3 650 | 114 443 | |||||
| 2017-06-01 | 2017-05-30 | 4 | Novak Rodger | CRSP | Common Shares | D | 15,0216 | −3 650 | −55 | 1 215 005 | ||||
| 2017-06-01 | 2017-05-30 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 3 650 | 7 | 1 218 655 | ||||
| 2017-05-18 | 2017-05-17 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −25 923 | 118 093 | |||||
| 2017-05-18 | 2017-05-17 | 4 | Novak Rodger | CRSP | Common Shares | D | 16,0312 | −25 923 | −416 | 1 215 005 | ||||
| 2017-05-18 | 2017-05-17 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 25 923 | 47 | 1 240 928 | ||||
| 2017-05-18 | 2017-05-16 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −24 077 | 144 016 | |||||
| 2017-05-18 | 2017-05-16 | 4 | Novak Rodger | CRSP | Common Shares | D | 16,5005 | −24 077 | −397 | 1 215 005 | ||||
| 2017-05-18 | 2017-05-16 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 24 077 | 44 | 1 239 082 | ||||
| 2017-05-09 | 2017-05-05 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −616 | 168 093 | |||||
| 2017-05-09 | 2017-05-05 | 4 | Novak Rodger | CRSP | Common Shares | D | 16,9248 | −616 | −10 | 1 215 005 | ||||
| 2017-05-09 | 2017-05-05 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 616 | 1 | 1 215 621 | ||||
| 2017-05-05 | 2017-05-03 | 4 | Kulkarni Samarth | CRSP | Stock Options (Right to Buy) | D | 16,21 | 100 000 | 100 000 | |||||
| 2017-05-04 | 2017-05-04 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −13 191 | 168 709 | |||||
| 2017-05-04 | 2017-05-04 | 4 | Novak Rodger | CRSP | Common Shares | D | 16,3718 | −13 191 | −216 | 1 215 005 | ||||
| 2017-05-04 | 2017-05-04 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 13 191 | 24 | 1 229 196 | ||||
| 2017-05-04 | 2017-05-03 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −20 269 | 181 900 | |||||
| 2017-05-04 | 2017-05-03 | 4 | Novak Rodger | CRSP | Common Shares | D | 16,6366 | −1 022 | −17 | 1 215 005 | ||||
| 2017-05-04 | 2017-05-03 | 4 | Novak Rodger | CRSP | Common Shares | D | 16,0536 | −19 247 | −309 | 1 216 027 | ||||
| 2017-05-04 | 2017-05-03 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 20 269 | 37 | 1 235 274 | ||||
| 2017-05-04 | 2017-05-02 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −50 000 | 202 169 | |||||
| 2017-05-04 | 2017-05-02 | 4 | Novak Rodger | CRSP | Common Shares | D | 16,5308 | −15 924 | −263 | 1 215 005 | ||||
| 2017-05-04 | 2017-05-02 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 15 924 | 29 | 1 230 929 | ||||
| 2017-05-03 | 2017-05-01 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 16,6055 | −1 852 | −31 | 168 204 | ||||
| 2017-04-28 | 2017-04-28 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 16,6201 | −4 912 | −82 | 170 056 | ||||
| 2017-04-28 | 2017-04-27 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 16,8403 | −13 527 | −228 | 174 968 | ||||
| 2017-04-28 | 2017-04-26 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 16,7627 | −3 200 | −54 | 180 495 | ||||
| 2017-04-28 | 2017-04-27 | 4 | Kulkarni Samarth | CRSP | Stock Options (Right to Buy) | D | 1,81 | −2 206 | 294 558 | |||||
| 2017-04-28 | 2017-04-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 16,7828 | −2 206 | −37 | 134 047 | ||||
| 2017-04-28 | 2017-04-27 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 2 206 | 4 | 136 253 | ||||
| 2017-04-28 | 2017-04-26 | 4 | Kulkarni Samarth | CRSP | Stock Options (Right to Buy) | D | 1,81 | −3 275 | 296 764 | |||||
| 2017-04-28 | 2017-04-26 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 16,7378 | −3 275 | −55 | 134 047 | ||||
| 2017-04-28 | 2017-04-26 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 3 275 | 6 | 137 322 | ||||
| 2017-04-25 | 2017-04-25 | 4 | Kulkarni Samarth | CRSP | Stock Options (Right to Buy) | D | 1,81 | −5 115 | 300 039 | |||||
| 2017-04-25 | 2017-04-25 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 16,8700 | −5 115 | −86 | 134 047 | ||||
| 2017-04-25 | 2017-04-25 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 5 115 | 9 | 139 162 | ||||
| 2017-04-25 | 2017-04-24 | 4 | Kulkarni Samarth | CRSP | Stock Options (Right to Buy) | D | 1,81 | −3 500 | 305 154 | |||||
| 2017-04-25 | 2017-04-24 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 16,4627 | −3 500 | −58 | 134 047 | ||||
| 2017-04-25 | 2017-04-24 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 3 500 | 6 | 137 547 | ||||
| 2017-04-25 | 2017-04-21 | 4 | Kulkarni Samarth | CRSP | Stock Options (Right to Buy) | D | 1,81 | −3 000 | 308 654 | |||||
| 2017-04-25 | 2017-04-21 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 17,0109 | −3 000 | −51 | 134 047 | ||||
| 2017-04-25 | 2017-04-21 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 3 000 | 5 | 137 047 | ||||
| 2017-04-25 | 2017-04-25 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 16,8729 | −4 800 | −81 | 183 695 | ||||
| 2017-04-25 | 2017-04-24 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 16,4387 | −3 522 | −58 | 188 495 | ||||
| 2017-04-25 | 2017-04-21 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 17,0174 | −3 010 | −51 | 192 017 | ||||
| 2017-04-21 | 2017-04-20 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 17,3732 | −2 937 | −51 | 195 027 | ||||
| 2017-04-21 | 2017-04-19 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 18,5782 | −2 310 | −43 | 197 964 | ||||
| 2017-04-21 | 2017-04-19 | 4 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 17,4948 | −4 930 | −86 | 200 274 | ||||
| 2017-04-21 | 2017-04-20 | 4 | Kulkarni Samarth | CRSP | Stock Options (Right to Buy) | D | 1,81 | −2 800 | 311 654 | |||||
| 2017-04-21 | 2017-04-20 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 17,3647 | −2 800 | −49 | 134 047 | ||||
| 2017-04-21 | 2017-04-20 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 2 800 | 5 | 136 847 | ||||
| 2017-04-21 | 2017-04-19 | 4 | Kulkarni Samarth | CRSP | Stock Options (Right to Buy) | D | 1,81 | −7 258 | 314 454 | |||||
| 2017-04-21 | 2017-04-19 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 18,5353 | −2 449 | −45 | 134 047 | ||||
| 2017-04-21 | 2017-04-19 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 17,5424 | −4 809 | −84 | 136 496 | ||||
| 2017-04-21 | 2017-04-19 | 4 | Kulkarni Samarth | CRSP | Common Shares | D | 1,8100 | 7 258 | 13 | 141 305 | ||||
| 2017-04-21 | 2017-04-20 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −2 294 | 218 093 | |||||
| 2017-04-21 | 2017-04-20 | 4 | Novak Rodger | CRSP | Common Shares | D | 17,3722 | −2 294 | −40 | 1 215 005 | ||||
| 2017-04-21 | 2017-04-20 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 2 294 | 4 | 1 217 299 | ||||
| 2017-04-21 | 2017-04-19 | 4 | Novak Rodger | CRSP | Stock Options (Right to Buy) | D | 1,81 | −47 706 | 220 387 | |||||
| 2017-04-21 | 2017-04-19 | 4 | Novak Rodger | CRSP | Common Shares | D | 18,6093 | −15 368 | −286 | 1 215 005 | ||||
| 2017-04-21 | 2017-04-19 | 4 | Novak Rodger | CRSP | Common Shares | D | 17,5669 | −32 338 | −568 | 1 230 373 | ||||
| 2017-04-21 | 2017-04-19 | 4 | Novak Rodger | CRSP | Common Shares | D | 1,8100 | 47 706 | 86 | 1 262 711 | ||||
| 2017-02-10 | 2016-10-24 | 4 | EMSTER KURT VON | CRSP | Series B Preferred Shares | I | 0,00 | −191 764 | 0 | |||||
| 2017-02-10 | 2016-10-24 | 4 | EMSTER KURT VON | CRSP | Series A-3 Preferred Shares | I | 0,00 | −2 354 050 | 0 | |||||
| 2017-02-10 | 2016-10-24 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 14,0000 | 56 000 | 784 | 2 601 814 | ||||
| 2017-02-10 | 2016-10-24 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 191 764 | 2 545 814 | ||||||
| 2017-02-10 | 2016-10-24 | 4 | EMSTER KURT VON | CRSP | Common Shares | I | 2 354 050 | 2 354 050 | ||||||
| 2017-02-10 | 2016-10-24 | 4 | Lundberg Sven Ante | CRSP | Series B Preferred Shares | D | 0,00 | −55 217 | 0 | |||||
| 2017-02-10 | 2016-10-24 | 4 | Lundberg Sven Ante By wife | CRSP | Common Shares | I | 14,0000 | 400 | 6 | 505 617 | ||||
| 2017-02-10 | 2016-10-24 | 4 | Lundberg Sven Ante | CRSP | Common Shares | D | 55 217 | 505 217 | ||||||
| 2016-12-23 | 3/A | Bolzon Bradley J PhD | CRSP | Common Shares | I | 684 014 | ||||||||
| 2016-12-23 | 3/A | Bolzon Bradley J PhD | CRSP | Common Shares | I | 239 648 | ||||||||
| 2016-12-23 | 3/A | Woiwode Thomas | CRSP | Common Shares | I | 239 648 | ||||||||
| 2016-12-23 | 3/A | Woiwode Thomas | CRSP | Common Shares | I | 684 014 | ||||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series B Preferred Shares | I | −5 774 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series B Preferred Shares | I | −13 180 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series B Preferred Shares | I | −5 210 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series B Preferred Shares | I | −173 167 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series B Preferred Shares | I | −1 454 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series B Preferred Shares | I | −231 077 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series A-3 Preferred Shares | I | −73 704 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series A-3 Preferred Shares | I | −168 224 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series A-3 Preferred Shares | I | −66 490 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series A-3 Preferred Shares | I | −2 210 417 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series A-2 Preferred Shares | I | −19 524 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series A-2 Preferred Shares | I | −3 100 477 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series A-1 Preferred Shares | I | −2 754 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. | CRSP | Series A-1 Preferred Shares | I | −437 247 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 5 774 | 79 478 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 73 704 | 73 704 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 14,0000 | 4 583 | 64 | 185 987 | ||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 13 180 | 181 404 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 168 224 | 168 224 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 5 210 | 71 700 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 66 490 | 66 490 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 14,0000 | 60 219 | 843 | 2 443 803 | ||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 173 167 | 2 383 584 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 2 210 417 | 2 210 417 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 14,0000 | 602 | 8 | 24 334 | ||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 1 454 | 23 732 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 19 524 | 22 278 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 2 754 | 2 754 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 14,0000 | 95 596 | 1 338 | 4 104 045 | ||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 231 077 | 4 008 449 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 3 100 477 | 3 777 372 | ||||||
| 2016-12-23 | 2016-10-24 | 4/A | Versant Venture Capital IV, L.P. Footnote | CRSP | Common Stock | I | 437 247 | 676 895 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series B Preferred Shares | I | −5 774 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series B Preferred Shares | I | −13 180 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series B Preferred Shares | I | −5 210 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series B Preferred Shares | I | −173 167 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series B Preferred Shares | I | −1 454 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series B Preferred Shares | I | −231 077 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series A-3 Preferred Shares | I | −73 704 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series A-3 Preferred Shares | I | −168 224 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series A-3 Preferred Shares | I | −66 490 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series A-3 Preferred Shares | I | −2 210 417 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series A-2 Preferred Shares | I | −19 524 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series A-2 Preferred Shares | I | −3 100 477 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series A-1 Preferred Shares | I | −2 754 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Series A-1 Preferred Shares | I | −437 247 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 5 774 | 79 478 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 73 704 | 73 704 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 14,0000 | 4 583 | 64 | 185 987 | ||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 13 180 | 181 404 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 168 224 | 168 224 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 5 210 | 71 700 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 66 490 | 66 490 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 14,0000 | 60 219 | 843 | 2 443 803 | ||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 173 167 | 2 383 584 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 2 210 417 | 2 210 417 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 14,0000 | 602 | 8 | 24 334 | ||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 1 454 | 23 732 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 19 524 | 22 278 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 2 754 | 2 754 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 14,0000 | 95 596 | 1 338 | 4 104 045 | ||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 231 077 | 4 008 449 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 3 100 477 | 3 777 372 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Bolzon Bradley J PhD | CRSP | Common Stock | I | 437 247 | 676 895 | ||||||
| 2016-12-23 | 2016-10-18 | 4 | Bolzon Bradley J PhD | CRSP | Stock Option (Right to Buy) | I | 14,00 | 30 000 | 60 000 | |||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series B Preferred Shares | I | −5 774 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series B Preferred Shares | I | −13 180 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series B Preferred Shares | I | −5 210 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series B Preferred Shares | I | −173 167 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series B Preferred Shares | I | −1 454 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series B Preferred Shares | I | −231 077 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series A-3 Preferred Shares | I | −73 704 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series A-3 Preferred Shares | I | −168 224 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series A-3 Preferred Shares | I | −66 490 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series A-3 Preferred Shares | I | −2 210 417 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series A-2 Preferred Shares | I | −19 524 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series A-2 Preferred Shares | I | −3 100 477 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series A-1 Preferred Shares | I | −2 754 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Series A-1 Preferred Shares | I | −437 247 | 0 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 5 774 | 79 478 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 73 704 | 73 704 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 14,0000 | 4 583 | 64 | 185 987 | ||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 13 180 | 181 404 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 168 224 | 168 224 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 5 210 | 71 700 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 66 490 | 66 490 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 14,0000 | 60 219 | 843 | 2 443 803 | ||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 173 167 | 2 383 584 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 2 210 417 | 2 210 417 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 14,0000 | 602 | 8 | 24 334 | ||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 1 454 | 23 732 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 19 524 | 22 278 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 2 754 | 2 754 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 14,0000 | 95 596 | 1 338 | 4 104 045 | ||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 231 077 | 4 008 449 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 3 100 477 | 3 777 372 | ||||||
| 2016-12-23 | 2016-10-24 | 4 | Woiwode Thomas | CRSP | Common Stock | I | 437 247 | 676 895 | ||||||
| 2016-12-23 | 2016-10-18 | 4 | Woiwode Thomas | CRSP | Stock Option (Right to Buy) | I | 14,00 | 30 000 | 60 000 | |||||
| 2016-10-27 | 2016-10-24 | 4/A | CELGENE CORP /DE/ See Explanation of Responses | CRSP | Series B Preferred Shares | I | 0,00 | −4 034 830 | 0 | |||||
| 2016-10-27 | 2016-10-24 | 4/A | CELGENE CORP /DE/ See Explanation of Responses | CRSP | Common Stock | I | 14,0000 | 800 150 | 11 202 | 4 834 980 | ||||
| 2016-10-27 | 2016-10-24 | 4/A | CELGENE CORP /DE/ See Explanation of Responses | CRSP | Common Stock | I | 4 034 830 | 4 034 830 | ||||||
| 2016-10-26 | 2016-10-24 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | 14,0000 | 4 583 | 64 | 185 987 | ||||
| 2016-10-26 | 2016-10-24 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | 14,0000 | 60 219 | 843 | 2 443 803 | ||||
| 2016-10-26 | 2016-10-24 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | 14,0000 | 602 | 8 | 24 334 | ||||
| 2016-10-26 | 2016-10-24 | 4 | Versant Venture Capital IV, L.P. | CRSP | Common Stock | I | 14,0000 | 95 596 | 1 338 | 4 104 045 | ||||
| 2016-10-26 | 2016-10-24 | 4 | COLES N ANTHONY By Coles Family Trust | CRSP | Common Stock | I | 14,0000 | 35 000 | 490 | 70 000 | ||||
| 2016-10-26 | 2016-10-24 | 4 | COLES N ANTHONY By wife | CRSP | Common Stock | I | 14,0000 | 35 000 | 490 | 70 000 | ||||
| 2016-10-26 | 2016-10-24 | 4 | GLAXOSMITHKLINE PLC See explanation of responses | CRSP | Series B Preferred Shares | I | −211 567 | 0 | ||||||
| 2016-10-26 | 2016-10-24 | 4 | GLAXOSMITHKLINE PLC See explanation of responses | CRSP | Series A-3 Preferred Shares | I | −2 942 560 | 0 | ||||||
| 2016-10-26 | 2016-10-24 | 4 | GLAXOSMITHKLINE PLC See explanation of responses | CRSP | Common Shares | I | 14,0000 | 66 500 | 931 | 3 220 627 | ||||
| 2016-10-26 | 2016-10-24 | 4 | GLAXOSMITHKLINE PLC See explanation of responses | CRSP | Common Shares | I | 211 567 | 3 154 127 | ||||||
| 2016-10-26 | 2016-10-24 | 4 | GLAXOSMITHKLINE PLC See explanation of responses | CRSP | Common Shares | I | 2 942 560 | 2 942 560 | ||||||
| 2016-10-26 | 2016-10-24 | 4 | George Simeon See explanation of responses | CRSP | Series B Preferred Shares | I | −211 567 | 0 | ||||||
| 2016-10-26 | 2016-10-24 | 4 | George Simeon See explanation of responses | CRSP | Series A-3 Preferred Shares | I | −2 942 560 | 0 | ||||||
| 2016-10-26 | 2016-10-24 | 4 | George Simeon See explanation of responses | CRSP | Common Shares | I | 14,0000 | 66 500 | 931 | 3 220 627 | ||||
| 2016-10-26 | 2016-10-24 | 4 | George Simeon See explanation of responses | CRSP | Common Shares | I | 211 567 | 3 154 127 | ||||||
| 2016-10-26 | 2016-10-24 | 4 | George Simeon See explanation of responses | CRSP | Common Shares | I | 2 942 560 | 2 942 560 | ||||||
| 2016-10-26 | 2016-10-24 | 4 | CELGENE CORP /DE/ | CRSP | Series B Preferred Shares | D | 0,00 | −4 034 830 | 0 | |||||
| 2016-10-26 | 2016-10-24 | 4 | CELGENE CORP /DE/ | CRSP | Common Stock | D | 14,0000 | 800 150 | 11 202 | 4 834 980 | ||||
| 2016-10-26 | 2016-10-24 | 4 | CELGENE CORP /DE/ | CRSP | Common Stock | D | 4 034 830 | 4 034 830 | ||||||
| 2016-10-24 | 2016-10-24 | 4 | Hadley Harbor Master Investors (Cayman) L.P. | CRSP | Series B Convertible Preferred Shares | D | −744 380 | 0 | ||||||
| 2016-10-24 | 2016-10-24 | 4 | Hadley Harbor Master Investors (Cayman) L.P. | CRSP | Common Shares | D | 744 380 | 744 380 | ||||||
| 2016-10-20 | 2016-10-18 | 4 | Woiwode Thomas | CRSP | Stock Option (Right to Buy) | D | 14,00 | 30 000 | 30 000 | |||||
| 2016-10-20 | 2016-10-18 | 4 | George Simeon | CRSP | Stock Option (Right to Buy) | D | 14,00 | 30 000 | 30 000 | |||||
| 2016-10-20 | 2016-10-18 | 4 | CAGNONI PABLO J | CRSP | Stock Option (Right to Buy) | D | 14,00 | 15 000 | 15 000 | |||||
| 2016-10-20 | 2016-10-18 | 4 | COLES N ANTHONY | CRSP | Stock Option (Right to Buy) | D | 14,00 | 15 000 | 15 000 | |||||
| 2016-10-20 | 2016-10-18 | 4 | EMSTER KURT VON | CRSP | Stock Option (Right to Buy) | D | 14,00 | 30 000 | 30 000 | |||||
| 2016-10-20 | 2016-10-18 | 4 | Bolzon Bradley J PhD | CRSP | Stock Option (Right to Buy) | D | 14,00 | 30 000 | 30 000 | |||||
| 2016-10-20 | 2016-10-18 | 4 | GLAXOSMITHKLINE PLC See explanation of responses | CRSP | Stock Option | I | 14,00 | 30 000 | 30 000 | |||||
| 2016-10-20 | 2016-10-18 | 4 | Behbahani Ali | CRSP | Stock Option (Right to Buy) | D | 14,00 | 30 000 | 30 000 | |||||
| 2016-10-20 | 2016-10-18 | 4 | Novak Rodger | CRSP | Stock Option (Right to Buy) | D | 14,00 | 200 000 | 200 000 | |||||
| 2016-10-18 | 3 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 923 662 | ||||||||
| 2016-10-18 | 3 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 821 303 | ||||||||
| 2016-10-18 | 3 | Bolzon Bradley J PhD | CRSP | Common Shares | D | 923 662 | ||||||||
| 2016-10-18 | 3 | Bolzon Bradley J PhD | CRSP | Common Shares | I | 821 303 | ||||||||
| 2016-10-18 | 3 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 410 408 | ||||||||
| 2016-10-18 | 3 | Dylan-Hyde Tyler | CRSP | Common Shares | D | 410 408 | ||||||||
| 2016-10-18 | 3 | Lundberg Sven Ante | CRSP | Common Shares | D | 955 217 | ||||||||
| 2016-10-18 | 3 | Lundberg Sven Ante | CRSP | Series B Preferred Shares | D | 560 434 | ||||||||
| 2016-10-18 | 3 | Lundberg Sven Ante | CRSP | Common Shares | D | 955 217 | ||||||||
| 2016-10-18 | 3 | Lundberg Sven Ante | CRSP | Series B Preferred Shares | D | 560 434 | ||||||||
| 2016-10-18 | 3 | Novak Rodger | CRSP | Common Shares | D | 2 430 010 | ||||||||
| 2016-10-18 | 3 | Novak Rodger | CRSP | Common Shares | D | 2 430 010 | ||||||||
| 2016-10-18 | 3 | Versant Ophthalmic Affiliates I, L.P. See footnotes | CRSP | Common Shares | I | 479 296 | ||||||||
| 2016-10-18 | 3 | Versant Ophthalmic Affiliates I, L.P. See footnotes | CRSP | Common Shares | I | 479 296 | ||||||||
| 2016-10-18 | 3 | Versant Ophthalmic Affiliates I, L.P. See footnotes | CRSP | Common Shares | I | 479 296 | ||||||||
| 2016-10-18 | 3 | Versant Ophthalmic Affiliates I, L.P. See footnotes | CRSP | Common Shares | I | 479 296 | ||||||||
| 2016-10-18 | 3 | Versant Ophthalmic Affiliates I, L.P. See footnotes | CRSP | Common Shares | I | 479 296 | ||||||||
| 2016-10-18 | 3 | Versant Ophthalmic Affiliates I, L.P. See footnotes | CRSP | Common Shares | I | 479 296 | ||||||||
| 2016-10-18 | 3 | Versant Ophthalmic Affiliates I, L.P. See footnotes | CRSP | Common Shares | I | 479 296 | ||||||||
| 2016-10-18 | 3 | Woiwode Thomas | CRSP | Common Shares | D | 923 662 | ||||||||
| 2016-10-18 | 3 | Woiwode Thomas | CRSP | Common Shares | I | 821 303 | ||||||||
| 2016-10-18 | 3 | Woiwode Thomas | CRSP | Common Shares | D | 923 662 | ||||||||
| 2016-10-18 | 3 | Woiwode Thomas | CRSP | Common Shares | I | 821 303 | ||||||||
| 2016-10-18 | 3 | Kulkarni Samarth | CRSP | Common Shares | D | 268 094 | ||||||||
| 2016-10-18 | 3 | Kulkarni Samarth | CRSP | Common Shares | D | 268 094 | ||||||||
| 2016-10-18 | 3 | BAYER AKTIENGESELLSCHAFT | CRSP | Common Shares | D | 10 210 660 | ||||||||
| 2016-10-18 | 3 | BAYER AKTIENGESELLSCHAFT | CRSP | Common Shares | D | 10 210 660 | ||||||||
| 2016-10-18 | 3 | BAYER AKTIENGESELLSCHAFT | CRSP | Common Shares | D | 10 210 660 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
